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Tracking Cell Fate with Synthetic Memory and Pulse Detecting Transcriptional Circuits 
 
ABSTRACT 
 
Synthetic biology aims to engineer biological systems to meet new challenges and teach us more about 
natural biological systems. These pursuits range from the building of relatively simple transcriptional 
circuits, to engineering the metabolism of an organism, to reconstructing entire genomes. While we are 
still emerging from the foundational stages of this new field, we are already using engineered cells to 
discover underlying biological mechanisms, develop new therapeutics, and produce natural products. In 
this dissertation, we discuss the application of synthetic biology principles to the development of 
memory and pulse-detecting genetic circuits. In Chapter 2, we use novel transcriptional positive-
feedback based memory devices integrated in human cells to study heterogeneous responses to cellular 
stresses. We built doxycycline, hypoxia, and DNA damage sensing versions of the device, demonstrating 
its modularity. In Chapter 3, we discuss further applications of the memory device in the study of long-
term responses to hypoxia, gamma radiation, and inflammation. Finally, in Chapter 4 we describe work 
leading to the future construction of a pulse-detecting genetic circuit integrated in the E. coli genome. 
The work presented here illustrates the general applicability of synthetic biology in the study of 
biological phenomena and brings us one step closer to achieving a more exquisite understanding and 
control of natural systems. 
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Introduction to synthetic circuits1 
Synthetic biology encompasses a vast range of pursuits including building novel transcriptional 
circuits(Gardner, Cantor, and Collins 2000; Ajo-Franklin et al. 2007), engineering metabolism on a 
large-scale(Wang et al. 2009), and creating a minimal cell(Gardner, Cantor, and Collins 2000; Forster 
and Church 2006; Ajo-Franklin et al. 2007). Early projects were mostly limited to building small genetic 
circuits consisting of only a few parts(Gardner, Cantor, and Collins 2000; Basu et al. 2005; Ajo-Franklin 
et al. 2007; Wang et al. 2009), however current work has extended our range to large multi-gene 
devices(Xie et al. 2011) and even entire chromosomes and genomes(Gibson et al. 2010; Annaluru et al. 
2014) The history of the field of synthetic biology has been described in great detail 
elsewhere(Cameron, Bashor, and Collins 2014; Way et al. 2014). 
 While some of the first synthetic circuits were built from a small number of parts, they exhibited 
complex behavior including oscillations and pattern formation(Basu et al. 2005). Cellular memory 
circuits were also among these early synthetic devices(Gardner, Cantor, and Collins 2000). Cellular 
memory refers to the cell’s ability to convert a transient signal or stimulus into a sustained response. 
Biological phenomena that rely on natural memory circuits include the lambda phage switch, cellular 
differentiation, and cell division(Ptashne 2004; Burrill and Silver 2010).  Synthetic memory circuits can 
either require active cellular processes to maintain their state (volatile memory) or not (non-volatile 
memory). Volatile memory circuits include transcription-based devices, while non-volatile memory 
circuits can be based on recombination. An important feature of volatile memory circuits is they are 
bistable – they tend to exist in one of two states and stochastic switching between the stable states 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Portions of this Chapter are reproduced with permission of the Elsevier from the following published work: 
Inniss MC, Silver PA. 2013. Building synthetic memory. Curr Biol 23:R812–6. 
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should be rare(Ferrell 2002). Additionally, the change in state of both volatile and non-volatile memory 
circuits can be reversible or irreversible (Figure 1.1A). 
 
 
Figure 1.1. Cellular memory circuits can be built in many ways. (A) The change in state of synthetic 
memory circuits can be either reversible or irreversible. (B) In vitro memory circuits rely on 
hybridization of nucleic acids. Interlocking negative and positive feedback loops form the bistable core 
(in box) of such devices. Once activated, each positive feedback loop produces an oligonucleotide that 
promotes its own production as well as an inhibitory oligonucleotide to the opposing positive feedback 
loop.  (C-F) In vivo memory circuits are built using diverse strategies. (C) Recombination-based 
memory circuits can be based on excision or inversion of DNA sequences. (D) Both positive and double 
negative transcriptional feedback loops can be used to engineer cellular memory. Novel memory circuits 
based on (E) protein phosphorylation and (F) RNA editing have also been proposed. 
 
  Synthetic memory circuits can be engineered using a variety of biological mechanisms including 
nucleic acid hybridization, DNA recombination, chromatin modification, transcription, and post-
Current Biology
In vitro In vivo
Inactive
Active
Signal
Signal
Excision
Inversion
Positive feedback     Double negative feedback RNA editing
Phosphorylation
C
D
EB
F
Signal 1 Signal 2
Nucleic acid hybridization
Time
Time
Signal
Signal 1 Signal 2
St
at
e
St
at
e
A
Reversible memory
Irreversible memory
	   4 
transcriptional phenomena. Here we will explore the current state of engineered memory circuits and 
their applications. We will then discuss the future of these devices in medicine and industry. 
 
In vitro memory circuits 
Synthetic genetic circuits can be constructed in vitro. These circuits consist solely of DNA, capable of 
performing calculations or logic functions via hybridization(Qian, Winfree, and Bruck 2011), or more 
complex mixtures of DNA and purified enzymes that can carry out transcription and translation(Kim, 
White, and Winfree 2006; Padirac, Fujii, and Rondelez 2012). The advantage of building synthetic 
circuits in vitro is the high level of control over the environment in which the device will function 
(Hockenberry and Jewett 2012). This control results in increased predictability and allows careful 
unpacking and analysis of the specific interactions between circuit components. This detailed 
understanding should allow better predictions and interpretations of device behavior when it is 
introduced into the more complex worlds of the cell and multicellular organisms.  
 In particular, there have been several recent examples of in vitro toggle switches and memory 
devices based on hybridization of oligonucleotides.  One such circuit was built by engineering two 
mutually repressive DNA-hybridization based transcriptional switches(Kim, White, and Winfree 2006). 
The circuit consists of DNA oligonucleotides, and two enzymes: T7 RNA polymerase and RNase H. 
The presence of activating single stranded (ss) DNA, complementary to each switch, allows T7 RNA 
polymerase to transcribe inhibitory RNAs to the opposing switches while RNase H degrades the 
inhibitory RNAs. By careful balancing of production and degradation rates, bistable behavior is 
observed: depending on the initial amounts of the opposing activating ssDNAs production of one 
inhibitory RNA will completely suppress production of the other. Importantly, these results agree very 
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closely with model predictions. While this system is bistable, it is not switchable; the circuit output 
depends entirely on the initial state of the system(Kim, White, and Winfree 2006).  
While reversibility is not necessary for a synthetic memory device, it may prove a useful feature. 
Recently, an in vitro switchable memory circuit was engineered consisting of DNA oligonucleotides, 
DNA polymerase, an endonuclease, and an exonuclease(Padirac, Fujii, and Rondelez 2012). The 
bistable core of the circuit consists of four templates: two positive feedback loops, and two mutually 
repressive feedback loops. There are two additional templates that produce two activating 
oligonucleotides in response to external signals. In this case, these signals are the addition of additional 
complementary oligonucleotides. Each of the newly produced oligonucleotides interacts with the 
templates in the bistable core to promote their own production and repress production of the other. 
Thus, by adding the appropriate external stimulus, the circuit can be switched from one state to the 
other (Figure 1.1B). 
 While, in principle, these in vitro memory circuits could be modified to function in cells, these 
strategies for engineering bistability remain unexplored in vivo. However, these studies have produced 
extremely detailed mechanistic understanding that will benefit future efforts to transfer these devices 
into the cellular environment.  
 
Writing cellular memory into DNA 
Heritable memory encoded at the DNA level has been used in biological studies for many years(Stern 
and Fraser 2001). Developmental biologists use recombinase systems such as Cre:loxP to permanently 
mark cells of a given lineage, and to knock-out genes in specific cell types or at desired times(Nagy 2000; 
Srinivas et al. 2001). To accomplish this, transgenic animals are created carrying circuits in which a 
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reporter gene is interrupted by a transcriptional terminator flanked by loxP sites(Srinivas et al. 2001), or 
by replacing a gene of interest with a loxP flanked version(Nagy 2000). Cre recombinase expression is 
then put under the control of a tissue-specific or inducible promoter. Differentiation into a specific tissue 
or addition of an exogenous inducer results in expression of recombinase, which excises the DNA 
between the loxP sites creating either a functional reporter gene or knocking-out the gene of interest 
respectively. As a recombination event results in a change at the DNA sequence level, the change is 
irreversible and transmits memory of the stimulus heritably and permanently(Figure 1.1C).  
 By using invertases instead of standard recombinases, more complex multi-state memory 
circuits can be designed(Ham et al. 2008; Bonnet, Subsoontorn, and Endy 2012; Siuti, Yazbek, and T.K. 
Lu 2013)(Figure 1.1C) . For instance, a double inversion recombination switch was built in E. coli by 
constructing a plasmid with two overlapping inversion modules(Ham et al. 2008). A separate plasmid 
carried the two inducible invertase genes. The state of this device can be probed by using a carefully 
chosen set of primers. The presence or absence of certain amplicons not only indicates whether each 
inducer has been added, but also the order in which they were introduced. More recently, memory 
circuits have been integrated with logic gates by flanking combinations of terminators, promoters, or 
reporter genes by two different pairs of recombinase target sites(Bonnet et al. 2013; Siuti, Yazbek, and 
T.K. Lu 2013). Depending on the arrangement of these elements, all input logic gates (AND, OR, NOR, 
AND NAND) can be created. Additionally, multiple inversion-based memory circuits can be linked to 
build a genetic counter capable of indicating the number of pulses of inducer experienced by the 
cell(Friedland et al. 2009). As with the systems used in lineage tracing experiments(Nagy 2000; Srinivas 
et al. 2001), activation of these devices is irreversible. 
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 Recently a rewritable recombination based memory device was demonstrated in E. coli.  This 
recombinase addressable data (RAD) module consists of a promoter flanked by phage attachment sites, 
attB and attP, situated between two fluorescent protein genes(Bonnet, Subsoontorn, and Endy 2012). 
The device is “set” by expression of an integrase (Int), flipping the promoter and converting attB and 
attP sites to attL and attR sites, and reset by coexpression of Int and an excisionase (Xis), restoring the 
attB and attP sites. Depending on the orientation of the promoter, one of the two fluorescent proteins is 
produced. The state of the device is stable over many generations and can be switched back and forth 
reliably many times. A reversible memory circuit enables the design of a combinatorial genetic 
counter(Subsoontorn and Endy 2012). In contrast to a counter built from irreversible memory circuits – 
using N modules for N counts – a combinatorial counter with N modules can count to 2N(Subsoontorn 
and Endy 2012).  
 
Transmitting memory through transcriptional networks 
The vast majority of synthetic genetic circuits implemented in vivo rely on the successful engineering of 
transcriptional regulation. One of the best-understood transcriptional regulation systems, lambda phage, 
is an example of a natural memory circuit(Ptashne 2004). As such, several synthetic memory circuits are 
transcription-based(Gardner, Cantor, and Collins 2000; Kramer et al. 2004; Ajo-Franklin et al. 2007; 
Lou et al. 2010; Burrill and Silver 2011; Burrill et al. 2012). There are two main gene network topologies 
that can demonstrate sustained memory behavior; double negative feedback loops, and a positive 
feedback loop(Ferrell 2002)(Figure 1.1D). Both of these strategies have been explored in different 
contexts and each has advantages and disadvantages. While the former is a much simpler circuit with 
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fewer components to engineer, the latter, by virtue of its increased complexity, provides more options 
for modification and tuning. 
 An early example of a synthetic genetic circuit was an engineered toggle switch in E. 
coli(Gardner, Cantor, and Collins 2000). Inspired by the natural lambda phage immunity 
region(Ptashne 2004), which has previously been shown to function in a novel context(Toman et al. 
1985) and more recently used to build an antibiotic detecting memory device in gut bacteria(Kotula et 
al. 2014), a double-negative feedback circuit was constructed consisting of two repressors driven by 
constitutive promoters. Each repressor can repress synthesis of the other, therefore, when one repressor 
is expressed, the other is repressed, thus creating two stable states. Importantly, it is possible to 
selectively inactivate each repressor by the addition of a specific small molecule, permitting the device to 
switch states. Careful tuning of promoter strength based on the choice of repressor created toggle 
switches that demonstrated bistability and long-term memory. Later, similar synthetic switches were 
shown to function in mammalian cells demonstrating the modularity of the design(Kramer et al. 2004; 
Deans, Cantor, and Collins 2007). Recently, a toggle switch was combined with genetic logic circuits to 
create a switch that can be switched on and off by repeated addition of a single trigger molecule(Lou et 
al. 2010).  
 While several autoregulatory circuits were built having some degree of bistability(Becskei, 
Séraphin, and Serrano 2001; Isaacs et al. 2003; Kramer and Fussenegger 2005), the first positive 
feedback loop that predictably and reliably transmitted memory for many cell divisions was built in 
Saccharomyces cerevisiae(Ajo-Franklin et al. 2007). To create this device, the activities of several 
transcription factors under the control of a galactose inducible promoter were characterized and a 
computational model of the circuit was used to predict which of these would form a functional memory 
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circuit. Indeed, the model correctly predicted which of the transcription factors would succeed and 
which would fail. This memory device was later shown to be modular; when the galactose inducible 
promoter was replaced with the promoter for a DNA repair response gene, the circuit maintained its 
activity albeit while responding to DNA damage instead of galactose(Burrill and Silver 2011). This 
reengineered circuit was able to identify a subpopulation of cells that maintained a differential response 
to DNA damage for many generations post-exposure. As with the toggle switch, the modularity of the 
positive feedback based memory device extends to its transferability to a different organism. A similar 
device designed to either respond to doxycycline, ultraviolet radiation, or hypoxia was built in human 
cells and was successfully used to isolate a subpopulation of cells that responded differentially to these 
stimuli(Burrill et al. 2012). 
 
Memory after transcription  
While cellular memory circuits have been engineered that operate at the DNA sequence level as well as 
through regulation of transcription, post-transcriptional processes have yet to be explored. Natural 
systems exhibit bistability and even memory dependent on processes such as 
phosphorylation(Gunawardena 2005) and post-transcriptional modification of RNA(Salz and Erickson 
2010). Recent efforts to model these systems open the possibility of harnessing them in engineered 
circuits.  
The phosphorylation state of proteins with multiple phosphorylation sites has been shown to be 
switch-like or bistable(Gunawardena 2005).  For example, multi-site phosphorylation is thought to 
contribute to the bistability of the MAP kinase cascade(Hadač, Schreiber, and Přibyl 2013). Other 
models predict that scaffolding is also a significant contributor to bistable phosphorylation 
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cascades(Chan et al. 2012). Now, synthetic phosphorylation based circuits can be built to test these 
predictions, adding protein phosphorylation to the selection of tools available for engineering cellular 
memory(Figure 1.1E). This will allow synthetic biologists to build novel circuits that can respond on 
much quicker timescales than transcriptional or recombination based circuits.  
As another point of post-transcriptional regulation, translation level and thus protein level, can 
be controlled through RNA modifications. Recently, construction of a positive feedback loop dependent 
on control of mRNA polyadenylation has been proposed(Aslam and Shouval 2012)(Figure 1.1F). 
Transcripts with more polyadenylation are more likely to be translated compared to those 
without(Gallie 1991; Wilusz, Wormington, and Peltz 2001). By encoding expression of a 
polyadenylating enzyme on a transcript carrying its cognate polyadenylation signal, a positive feedback 
loop can be created(Aslam and Shouval 2012). This circuit has the potential to be bistable, making it a 
candidate for becoming the basis of a cellular memory device. These diverse methods of creating cellular 
memory will provide a powerful toolkit for building future synthetic circuits. 
 
Pulse detection and generation 
While numerous strategies for building a memory device have been discussed, these circuits are 
triggered whether or not the stimulus has ended. This ability to distinguish between subsequent events is 
necessary for one of the more complex applications of memory devices: counting(Bonnet, Subsoontorn, 
and Endy 2012; Subsoontorn and Endy 2012). In order to avoid advancing a counter prematurely, the 
synthetic circuit must be able to distinguish between a pulse of stimulus and a sustained stimulus (a 
single long pulse). Pulse detecting circuits are usually triggered by either the rising or falling edge 
(beginning or ending) of a pulse of stimulus. A rising edge detector can also be characterized as a pulse 
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generator as it produces a burst of output in response to inducer regardless of continued induction. This 
temporal behavior can be achieved through an incoherent feedforward loop; one component of a 
cascade represses an earlier component(Kaplan et al. 2008). Many natural examples exist(Kuttykrishnan 
et al. 2010; Nir Yosef 2011) and, indeed, examples of this type of circuit have been engineered(Basu et 
al. 2004). However, a falling edge detector has yet to be built. 
 
Learning through building 
Synthetic biologists have envisioned what may be possible once we can reliably and predictably 
reengineer biology. While building novel genetic circuits both in vitro and in vivo has been a pursuit of 
synthetic biologists for several years, most of these have yet to find utility in real world applications. 
Nevertheless, these early efforts have proven useful both as research tools and in gaining a better 
understanding of natural biological mechanisms(Figure 1.2A). Synthetic memory circuits have been 
used to explore what is needed to engineer bistability. In particular, transcription-based circuits have 
been extensively modeled(Rodrigo and Jaramillo 2007; Ghim and Almaas 2009; Widder, Macía, and 
Solé 2009; Rodrigo et al. 2010) and many examples have been built in diverse contexts(Gardner, 
Cantor, and Collins 2000; Kramer et al. 2004; Ajo-Franklin et al. 2007; Lou et al. 2010; Burrill and Silver 
2011; Burrill et al. 2012). The knowledge gained through these pursuits will allow synthetic biologists to 
better understand natural and novel transcriptional networks. In addition, memory circuits have been 
used to study biological questions that would be otherwise intractable. As described earlier, 
recombination based memory circuits have been used extensively to trace developmental lineages of 
cells (Stern and Fraser 2001). These circuits also allow conditional gene knock-outs, making it possible 
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to study the effects of gene loss in certain cell types and at specific times during development(Nagy 
2000). 
 
 
Figure 1.2. Engineered cellular memory circuits can be used to study biology and may be used to 
diagnosis and treat disease, as well as solve unmet industrial needs. (A) Memory circuits can be used to 
study heterogeneously responding cell populations. (B) When a cell changes from a healthy to a disease 
state, memory circuits can detect and report this change or treat the underlying condition. (C) Memory 
circuits will allow long-term expression by transient addition of inducer. 
 
 Synthetic memory circuits based on transcriptional positive feedback loops have been used to 
study the long-term effects of transient stimuli in S. cerevisiae and human cells(Burrill and Silver 2011; 
Burrill et al. 2012). S. cerevisiae carrying the DNA damage responsive memory circuit were exposed to 
genotoxic doses of EMS or hydroxyurea. Due to the nature of the bistable circuit, cells only switch to the 
memory state if they respond above a certain threshold allowing isolation of a more strongly responsive 
subpopulation. This subpopulation was shown to have a higher rate of mitochondrial activity and iron 
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uptake and this phenotype persisted for many generations post-exposure(Burrill and Silver 2011). 
Similarly, a DNA damage responsive memory device in human cells was also used to isolate a 
subpopulation of strongly responding cells. Gene expression in these memory cells differed from the 
non-memory population for many days post-exposure to UV radiation(Burrill et al. 2012). Thus, using 
synthetic memory circuits, we can mark and influence biologically relevant subpopulations of cells.  
 
The future of engineered cellular memory 
While synthetic memory devices have been useful in learning more about biology and the function of 
genetic networks, we expect that in the future, these circuits will find new applications in fields such as 
medicine or industrial biotechnology(Figure 1.2B-C). Other types of synthetic circuits and engineered 
cells are already being explored as potential next-generation therapies in the treatment of diseases such 
as diabetes, metabolic syndrome, and cancer(Burrill, Boyle, and Silver 2011; Ruder, T. Lu, and Collins 
2011; Weber and Fussenegger 2011; Ye et al. 2013). The ability to induce a sustained response to a 
transient stimulus will enable new forms of treatment and diagnosis as well as meet unsolved industrial 
challenges(Ruder, T. Lu, and Collins 2011). 
Current medical treatment relies on diagnosis of a disease before an appropriate treatment can 
be administered and, often, a patient will have to take repeated doses of a drug over the course of 
treatment(Folcher and Fussenegger 2012; Wieland and Fussenegger 2012). A synthetic memory circuit 
could be engineered to detect a biological signal of disease and start producing either an easily detectable 
reporter or a therapeutic(Figure 1.2B). Transcriptional positive feedback loops have already been shown 
to be modular and thus can be coupled to different biological signaling pathways to detect transient 
changes in the biology of the cell(Burrill and Silver 2011). Alternatively the device can be engineered to 
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respond to an extracellular stimulus, such as radiation or hypoxia. These devices will allow a physician to 
know whether a certain stimulus or condition has occurred even if it is no longer present. While the 
output of the memory device can be a reporter that can easily be detected such as a fluorophore, beta-
galactosidase, or secreted alkaline phosphatase, in the future, the output of these devices may be a 
therapeutic(Ausländer and Fussenegger 2012). This will automate both the detection and treatment of 
disease, decreasing the time between the start of the condition and the first dose of therapy(Figure 
1.2B). 
Cellular memory devices will also be useful in an industrial setting. One barrier to cost-effective 
production of chemical products is the cost of constantly inducing the culture(Siuti, Yazbek, and T.K. 
Lu 2013). A synthetic memory device would convert transient induction of a large culture into 
permanent expression of the exogenous biosynthetic pathways of interest, significantly reducing the cost 
of production(Siuti, Yazbek, and T.K. Lu 2013)(Figure 1.2C). In addition, one can imagine designing a 
synthetic memory circuit to be activated at a certain cell density or other internal condition eliminating 
the need for an external inducer.  
 
Conclusions 
Engineering synthetic memory circuits has already taught us about designing bistability and building 
genetic circuits both in vitro and in vivo, and helped answer diverse biological questions. However, there 
remain unmet needs that will enable new applications. Namely, more diverse and well characterized 
parts – e.g. transcription factors, recombinases, and inducible promoters – as well as more predictive 
models describing the interactions of these parts. As we apply this deepened understanding and 
incorporate new tools such as phosphorylation and RNA modification, more complex systems will be 
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designed and implemented making these devices an important part of next generation medical 
treatments and bioindustry. 
In this dissertation, we will discuss the use of synthetic biology approaches for tracking cell fate 
and detecting pulsed stimuli. In Chapter 2, the engineering of transcriptional memory devices that can 
sense and respond to doxycycline, hypoxia, and DNA damage is described. We show that using a 
positive feedback loop, we can create a device capable of transmitting memory of exposure to a given 
stimulus through cell division. Additionally, this device can be used to segment a heterogeneously 
responding population of cells and allows isolation of a differentially responding subpopulation. In 
Chapter 3, we explore further applications of the memory device described earlier. These include further 
study of a long-term response to transient hypoxia, memory of exposure to γ-radiation, and 
development of an inflammation-responsive memory device. Finally, in Chapter 4, the design of a pulse-
detecting genetic circuit and characterization of its components is discussed. Such a circuit would allow 
the assembly of far more complex circuits such as an event counter.  
I have also included reprints of the papers I wrote as a graduate student as Appendices. 
Appendix D is a research paper describing the development of the mammalian transcriptional memory 
devices. Appendix E is the publication coming from the Harvard 2010 iGEM team introducing plants as 
a chassis for synthetic biology in the iGEM competition. Lastly, Appendix F is a review of the current 
state of building synthetic memory circuits.  
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Abstract1 
A variety of biological phenomena, from disease progression to stem cell differentiation, are typified by a 
prolonged cellular response to a transient environmental cue. While biologically relevant, heterogeneity 
in these long-term responses is difficult to assess at the population level, necessitating the development 
of biological tools to track cell fate within subpopulations. Here we present a novel synthetic biology 
approach for identifying and tracking mammalian cell subpopulations. We constructed three 
genomically-integrated circuits that employ bistable auto-regulatory transcriptional feedback to retain 
memory of exposure to brief stimuli. These ‘memory devices’ are used to isolate and track the progeny of 
cells that responded differentially to doxycycline, DNA damaging agents, or hypoxia.  Following ultra-
violet radiation or hypoxic exposure, strongly responding cells activate the memory device and exhibit 
changes in gene expression, growth rates, and viability for multiple generations after the initial stimulus. 
Taken together, these results indicate that a heritable memory of DNA damage and hypoxia exists in 
subpopulations that differ in long-term cell behavior. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Portions of this chapter were reproduced with permission from Cold Spring Harbor Laboratory Press: 
Burrill DR, Inniss MC, Boyle PM, Silver PA. 2012. Synthetic memory circuits for tracking human cell fate. Genes Dev 
26:1486–1497. 
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Introduction 
Biological heterogeneity exists in most cell populations; even isogenic populations exhibit some natural 
cell-to-cell variability in parameters including gene expression and cell morphology (Bishop et al. 2006). 
Heterogeneity can result from factors such as noise in gene expression and signal transduction, 
epigenetic modifications, and cell age (Avery 2006; Bishop et al. 2006). A consequence of this diversity 
is that not all cells within a population will respond identically to a given stimulus. Biological systems can 
take advantage of such heterogeneity to produce specific cell types (e.g. differentiation) or optimize 
fitness in fluctuating environments (e.g. immunity) (Acar, Mettetal, and van Oudenaarden 2008). 
Conversely, heterogeneity can leave some cell subpopulations more sensitive to drug treatment (e.g. 
chemotherapy) or disease states (e.g. metastasis) (Murray-Zmijewski, Slee, and X. Lu 2008). Distinct 
cell fates can be heritably-encoded using multiple gene-regulatory strategies, including epigenetic marks, 
stable cytoplasmic factors, and transcriptional auto-regulatory circuits (Burrill and Silver 2011). Thus, 
biological diversity can produce cell subpopulations harboring different memories of an experienced 
stimulus. 
 By the very nature of its heterogeneity, memory of a biological decision is difficult to study. 
Population-scale data can obscure subpopulations (Bishop et al. 2006), and single-cell level experiments 
remain expensive, technically difficult, and hard to scale (Spiller et al. 2010). Studies of biological 
memory require a technique for tracking a cellular decision through cell division. Recombinase systems 
are commonly used to confer memory by leaving a permanent genomic mark, however, DNA 
rearrangement and recombinase expression can have off-target effects that negatively affect genomic 
fidelity (Forni et al. 2006). Furthermore, tunable, reversible DNA recombinase-based memory has only 
recently been demonstrated in bacteria (Bonnet 2012) and has yet to be developed in eukaryotic cells. 
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 One solution is the application of synthetic, transcriptional auto-regulatory circuits to track 
heritable, differential responses to a stimulus. In this circuit design, a stimulus induces transcription of a 
trigger gene expressing a transactivator, which binds the promoter of a second gene. The second gene 
produces more of the same transactivator, initiating a positive feedback loop, or memory (Figure 2.1A). 
Memory is self-sustainable when the input exceeds the circuit’s bistable threshold for feedback, allowing 
the circuit to switch to an alternative state that is transmitted through cell division. Examples of this in 
nature include the cell cycle and cell differentiation (Burrill and Silver 2010), and synthetic versions 
have been built in bacteria, yeast, and mammalian cells (for review, Haynes and Silver 2009; Burrill and 
Silver 2010). In recent work, we constructed a memory circuit in yeast that detects DNA repair, allowing 
for isolation of cells that initiated a repair response above the circuit’s bistable threshold (Burrill and 
Silver 2011). Strongly responsive cells exhibited a heritable damage response that was distinct from less 
responsive cells for many generations.  
Here we report the construction and implementation of synthetic memory circuits in human 
cells to track differential cellular decisions following a global stimulus. Activation of the device was 
linked to endogenous hypoxia and DNA damage response pathways, as these stressors elicit 
heterogeneous responses at the single-cell level (Bristow and Hill 2008; Murray-Zmijewski, Slee, and X. 
Lu 2008). A synthetic memory device that responds to low oxygen (O2) concentrations could help to 
study the sustained effects of hypoxic exposure during tumor formation. Hypoxia stabilizes the HIF-1 
transcription factor, which can activate or silence target genes, as well as increase genomic instability by 
mediating the bypass of DNA repair checkpoints (Chen et al. 2006; Bristow and Hill 2008; Denko 2008; 
Lee et al. 2009; Y. Lu et al. 2011). Tumors can harbor cell subpopulations that have been exposed to 
acute or chronic hypoxia and subsequently reoxygenated, and these tumors are associated with a more  
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Figure 2.1. Design and testing of trigger and loop genes. 
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Figure 2.1 (continued). Design and testing of trigger and loop genes. (A) Schematic of dox trigger, 
reporter, and loop genes. (B) Synthetic ZFs (BCR-ABL #1 & 2, HIV #1 & 2, erbB2 #1) were tested as 
transactivators via co-transfection with corresponding reporters. BCR-ABL #1 was also tested on a single 
plasmid with its corresponding reporter gene. (C) BCR-ABL #1 trigger and loop were tested via co-
transfection on separate plasmids. (D) BCR-ABL #1 trigger was adapted to be sensitive to DNA damage 
or hypoxia. (E) HRE and p53R2-RE triggers were tested via co-transfection with loop. (B, C, E) FACS 
determined % cells positive for trigger RFP and reporter or loop YFP. Values represent mean ± SE, n = 3. 
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aggressive disease(Bristow and Hill 2008). A memory device activated by HIF-1 could potentially 
detect, isolate, and track these subpopulations within the heterogeneous tumor microenvironment to 
determine their specific contributions toward tumor development and metastasis. 
 Like hypoxia, DNA damage also produces a complex array of biological responses at the single 
cell level. Linking a memory circuit to native DNA damage pathways could help identify how DNA 
damage responses are transmitted to subsequent generations and impact long-term cell behavior. The 
variable activation of the tumor suppressor p53 largely determines a single cell’s response to DNA 
damage (Murray-Zmijewski, Slee, and X. Lu 2008). A memory device triggered at the level of a p53-
induced repair factor, such as the ribonucleotide reductase p53R2, would facilitate the isolation and 
tracking of progeny whose ancestors underwent a repair response strong enough to activate the memory 
loop, versus those that did not (Tanaka et al. 2000). This could reveal how a cell’s specific history of 
DNA damage translates into long-term biological consequences.  
 Collectively, our work illustrates a novel, synthetic biology approach for studying cell 
heterogeneity and fate. The described genomically-integrated devices facilitate the investigation of 
biological questions that require long-term cell division and stable inheritance of a genetic circuit. The 
modularity of our system is demonstrated by the construction of memory circuits that respond to 
diverse and relevant stimuli. Our studies reveal the existence of a heritable biological memory of DNA 
damage and hypoxia, providing unique insight into protracted responses to transient stimuli.  
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Results 
Characterizing memory circuit components via transient transfection 
To engineer a memory device, we first designed a set of fluorescently-labeled synthetic transcriptional 
activators (triggers) and their corresponding reporter genes (Figure 2.1A,). Each trigger gene consisted 
of a synthetic zinc finger (ZF) DNA-binding domain (Hurt et al. 2003), one copy of the red fluorescent 
protein (RFP) mCherry (Shaner et al. 2004), the VP64 activation domain (Beerli et al. 1998), and a 
nuclear localization sequence (NLS) (Kalderon et al. 1984), all under the control of a doxycycline 
(dox)-inducible CMV-TetOx2 promoter with a human kozak sequence. ZFs were mammalian codon-
optimized versions of those previously engineered by Hurt, et al, to bind specifically to target DNA 
sequences in a BCR-ABL translocation (BCR-ABL #1, #2), the erbB2 gene (erbB2 #1), or the HIV 
promoter (HIV #1, #2) (Hurt et al. 2003). Each reporter gene had six tandem copies of DNA-binding 
sites for a given ZF upstream of a minimal promoter (composed of a TATA sequence and human kozak 
sequence), and its protein-coding region encoded two copies of the yellow fluorescent protein (YFP) 
variant Venus (Shaner, Steinbach, and Tsien 2005) tagged with an NLS (Figure 2.1A). In the presence 
of dox, trigger genes were expected to express RFP and a functional transactivator that should bind to its 
corresponding reporter binding sites, producing a YFP signal.  
 To evaluate functionality of our constructs in human cell culture, triggers and reporters were 
built on separate plasmids and transiently co-transfected in a U2OS cell line that expresses the Tet 
repressor (Table A.1). Following the addition of dox, trigger RFP and reporter YFP co-expression was 
monitored by fluorescence-activated cell sorting (FACS) (Figure 2.1B). All triggers activated 
transcription of their target reporters by at least 2-fold. HIV #2 reporter exhibited the most leaky 
expression, with over 10.0% of cells expressing YFP in the absence of dox. Trigger/reporter pairs were 
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specific and orthogonal to one another, as minimal YFP expression was observed when reporters alone 
(Figure A.1A) or mismatched trigger/reporter combinations (Figure A.1B) were transfected. Thus, all 
triggers were capable of producing a functional transcriptional circuit. 
 This set of synthetic transactivators provided the components to construct auto-regulatory 
loops intended to confer memory of a stimulus to a single cell and its progeny. In our proposed device, 
an input causes synthesis of an RFP-labeled transactivator, which activates expression of a 2xYFP-
labeled transactivator (Figure 2.1A). This protein binds to its own promoter and, given certain 
parameters, continues to self-activate in the absence of stimulus, resulting in sustained YFP expression. 
For simplicity, all memory devices were built with the BCR-ABL #1 domain, although the above 
transient experiments suggested that all tested ZFs would provide similar results. 
 Since tracking long-term memory requires a stably-integrated device, a trigger-reporter circuit 
was assembled on a single plasmid and tested by transient transfection for circuit activation to determine 
whether the circuit could be integrated in one step. On a single plasmid, the dox memory device 
demonstrated constitutive reporter YFP expression in the absence of dox, likely due to cis-activation 
caused by enhancer elements in the trigger’s CMV-TetOx2 promoter (Boshart et al. 1985) (Figure 
2.1B). However, the dox device demonstrated inducible expression of the loop gene when the trigger 
and loop were co-transfected on separate plasmids (Figure 2.1C).  
We next aimed to construct memory circuits capable of recording exposure to dox, hypoxia, or 
DNA damage. The hypoxia-inducible promoter we used was based on one previously engineered by 
Shibata, et al, and is composed of five copies of HIF-1 binding sites, known as hypoxia-responsive 
elements (HREs), ligated to a minimal human CMV promoter (Shibata, Giaccia, and Brown 2000). 
This promoter is activated when a cell triggers the HIF-1 pathway in response to hypoxia (Figure 2.1D). 
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A DNA damage-inducible promoter (p53R2-RE) was generated by linking four copies of the p53 
binding site in p53R2 (Ohno et al. 2008) to a minimal human CMV promoter (Shibata, Giaccia, and 
Brown 2000). This promoter is activated when a cell executes a p53R2-mediated repair response 
(Figure 2.1D).  
Unlike the dox device, the HRE and p53R2-RE triggers do not contain strong enhancer 
elements and can be assembled as a single construct with the loop gene. When the hypoxia and DNA 
damage devices were transfected as a single plasmid and exposed to the hypoxia mimic cobalt chloride or 
the DNA damaging-agent neocarzinostatin (NCS), respectively, RFP and YFP were co-expressed in a 
significant percentage of cells above basal levels (Figure 2.1E). These observations were similar whether 
or not the circuits were built on one plasmid (Figure A.1C). Thus, we determined that while a dox 
memory stable cell line would require two integrations, only one was necessary to produce DNA damage 
and hypoxia memory cell lines. To test the capacity of the loop element to retain memory of dox, 
hypoxia, or DNA damage exposure, we proceeded to genomically integrate the circuits. 
 
 
An integrated dox memory device 
The dox trigger and loop were randomly integrated as separate genes to create the cell line 
MD10/TetOx2 (Table A.2). Dox exposure resulted in trigger RFP and loop YFP expression in 99.8% 
and 42.7% of cells, respectively, as determined by FACS (Figure 2.2A) and fluorescence microscopy 
(Figure 2.2B). Upon the removal of dox, trigger RFP turned off in most cells within 1 d, while loop YFP 
achieved a bimodal distribution, such that two distinct memory and non-memory subpopulations co-
existed (Figure A.2). YFP expression persisted in a large percentage of cells for at least 3 d (~ 4 
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generations), suggesting heritable memory loop activity (Figure 2.2B). These traits were not specific to 
MD10/TetOx2, as multiple alternative clones were analyzed and demonstrated similar behavior (Figure 
A.3).  
Sustainable memory behavior within a subpopulation of dividing cells was further revealed in 
time-lapse fluorescence microscopy of cells recovering from dox exposure (Figure 2.2C, File A.1). 
Distribution of YFP intensity in the memory subpopulation was constant over time, suggesting 
persistent protein production (Figure 2.3A). Furthermore, spontaneous loop activation in the absence 
of dox was not observed when MD10/TetOx2 was cultured for 9 d (~ 10 generations), indicating that 
any loop activity was due solely to dox exposure (Figure 2.3B). To rule out a difference in RFP and YFP 
protein degradation rates as causal of the observed memory behavior, cells were exposed to dox to 
activate fluorophore expression, and cycloheximide was then added to inhibit protein biosynthesis. RFP 
and YFP degradation rates were determined to be approximately equivalent: 10.6 versus 11.5 arbitrary 
intensity units/h, respectively (Figure A.4). Thus, loop YFP protein persisted by positive feedback and 
not by protein stability. We concluded that MD10/TetOx2 was capable of recording dox exposure and 
transmitting memory of this response to progeny. 
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Figure 2.2. MD10/TetOx2 transmits memory of dox exposure. Memory behavior was analyzed by (A) 
FACS and (B) fluorescence microscopy. FACS determined % cells positive for trigger RFP and loop 
YFP. Values represent mean ± SE, n = 3. (C) Fluorescence microscopy montage of MD10/TetOx2 
post-dox exposure. Phase, RFP and YFP channels were overlaid.  Arrows: dividing memory cells. 
Asterisks: cells where the circuit does not remain active after division. 
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Figure 2.3.  Further characterization of MD10/TetOx2. (A) FACS plots of YFP intensity of memory 
loop cells only, versus event rate over time. (B) Unexposed cells were tracked via FACS to determine 
rate of spontaneous loop activation. (C) Memory and non-memory cells were sorted 2 d post-dox 
exposure and tracked by FACS to determine % cells positive for loop YFP. (D) Sorted memory and non-
memory cells were re-induced 3 d post-sort with dox, and FACS determined % cells positive for loop 
YFP. (E) Cells were exposed to dox, TSA, or TSA+dox to identify epigenetic silencing of the device. 
FACS determined % cells positive for trigger RFP and loop YFP. (A-E) Values represent mean ± SE, n = 
3. 
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the percentage that maintained loop expression decreased over time (Figure 2.3C).  Sorted memory 
cells were re-exposed 3 d post-sort to dox, at which time about 20.2% were still expressing the loop, but 
only 83.3% reactivated the loop (Figure 2.3D). Furthermore, sorted non-memory cells largely failed to 
re-induce the loop (Figure 2.3D). These observations suggested that epigenetic silencing might play a 
role in permanently deactivating the memory loop. To test this theory, trichostatin A (TSA) – a histone 
deacetylase inhibitor – was applied to unsorted MD10/TetOx2 cells before dox exposure to reverse 
gene silencing. While the number of cells expressing the trigger did not change, 12.5% more cells 
activated the memory loop if first exposed to TSA (Figure 2.3E), indicating that decreased loop activity 
over time could be due to epigenetic silencing. This may also explain why only 42.7% of cells initially 
activated the loop. Every selected MD10/TetOx2 clone exhibited this behavior, suggesting that the loop 
became silenced during the selection process. Despite this effect, however, this cell line exhibits 
persistent inducible memory loop expression in a significant percentage of cells, allowing for tracking of 
the cellular response to dox through cell division.  
 
An integrated hypoxia memory device 
To track memory of hypoxia through cell division, the stable cell line MD15/HRE was constructed via 
random genomic integration of the HRE trigger and loop as a single plasmid. While CoCl2 induced a 
hypoxic response in transient experiments, it was not appropriate for long-term cell tracking due to its 
deleterious effect on cell viability and possible non-specific activity as a hypoxia mimic. Alternatively, an 
anaerobic chamber caused less cell death and created an anoxic environment in which MD15/HRE 
could be easily characterized since the HRE promoter is maximally active under anoxic conditions 
(Shibata, Giaccia, and Brown 2000). As fluorophores require O2 to fold properly, any trigger or loop 
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protein produced during anoxia was not fluorescent, necessitating a recovery period before analysis. 
After 1 d of anoxic exposure and 1 d of recovery, the trigger was expressed in 21.5% of cells at a low 
intensity, since the anoxic response had likely subsided by that time, and the loop was activated in 10.8% 
of cells, as determined by FACS (Figure 2.4A) and fluorescence microscopy (Figure 2.4B). Loop-
expressing cells were expected to have activated the trigger’s anoxia-inducible promoter above the 
bistable threshold required for loop expression. A scatter plot of single cell RFP versus YFP intensities 
post-dox exposure shows that higher RFP expression corresponds to higher YFP expression, as 
measured by FACS (Figure A.5A). Thus, loop expression results from stronger trigger activation in 
response to anoxia. 
During the first 2 d post-exposure, we observed a decrease in the memory subpopulation as a 
fraction of the total population (Figure 2.4A). We hypothesized that memory cells, having activated a 
stronger response to anoxia, were likely more susceptible to growth defects and being diluted out of the 
population. This made it difficult to observe, by FACS, whether memory of anoxia indeed persisted 
through cell division within a subpopulation of cells (Figure A.6). By microscopy, however, we 
determined that memory was maintained in small clonal populations. When memory cells were isolated 
from their non-memory counterparts via cell sorting and observed by fluorescence microscopy, a 
significant proportion of sorted memory cells expressed the loop for at least 6 d (~ 5 generations) post-
sort and grew in clusters, indicating active maintenance of memory through cell division (Figure 2.4B). 
To determine the contribution of epigenetic silencing to the decrease in memory population, 
sorted non-memory cells were re-induced 6 d post-sort. Only 3.3% and 2.5% of sorted non-memory cells 
reactivated the trigger and loop, respectively (Figure 2.4C). In addition, when TSA was applied to 
unsorted MD15/HRE cells prior to anoxic exposure, 8.8% and 13.5% more cells activated the trigger  
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Figure 2.4. MD15/HRE device identifies a subpopulation with unique memory of low O2 exposure.  
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Figure 2.4 (continued). MD15/HRE device identifies a subpopulation with unique memory of low O2 
exposure. (A) Cells were exposed to anoxia, and tracked by FACS for 2 d. (B) Cells were exposed to 
anoxia and recovered for 1d. Memory cells (YFP+) were sorted and followed by microscopy for 6 d. (C) 
Cells were exposed to anoxia and recovered for 1d. Non-memory cells were sorted and re-exposed to 
anoxia 6 d post-sort. (D) Cells were exposed to dox, TSA, or TSA+anoxia to identify epigenetic 
silencing of the device. (E) Cells were exposed to hypoxia and tracked by FACS for 2 d. (A,C,D,E). 
FACS determined % cells positive for trigger RFP and loop YFP. Values represent mean ± SE, n = 3 (F) 
Cells were exposed to hypoxia and recovered for 1 d. MD10/TetOx2 was exposed to dox and recovered 
for 1 d. Cell death was measured in memory versus non-memory cells by FACS. Values represent mean 
± SE, n = 3. (G) MD15/HRE and U2OS cells were exposed to hypoxia, and HIF target gene expression 
was measured. Values represent mean fold expression change over unexposed cells ± SE, n = 3. (H) 
Cells were exposed to hypoxia and recovered for 1 d. Memory and non-memory cells were sorted, and 
HIF target gene expression was measured in each subpopulation. Values represent mean fold expression 
change in memory versus non-memory cells ± SE, n = 2. 
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and loop, respectively (Figure 2.4D), indicating that epigenetic silencing was occurring in this cell line. 
We also noted that the slower growth of memory cells contributed to a decrease in the percentage of 
loop-expressing cells. When equal numbers of sorted memory and non-memory cells were plated 1 d 
post-exposure, memory cells exhibited a growth defect, reaching confluency 1 d later than non-memory 
cells (Figure A.7A). This phenotype was not caused by synthetic gene expression, as no growth 
difference was observed between sorted MD10/TetOx2 memory and non-memory cells (Figure A.7B). 
In sum, epigenetic silencing and slow growth likely caused the observed decline in memory cells when 
memory and non-memory cells were co-cultured. 
 To interrogate the biological relevance of the subpopulations captured by the circuit, hypoxia 
(0.1% O2) was next used to activate the MD15/HRE device. While the trigger’s HRE promoter is 
known to be less active under increasing O2 conditions, hypoxia is commonly used to mimic a tumor 
microenvironment and plays a significant biological role in disease and development (Bristow and Hill 
2008). As expected, hypoxia activated the device in fewer cells (13.6% trigger RFP positive and 5.1% 
loop YFP positive) than anoxia, presumably due to the higher O2 concentration (Figure 2.4E, A.5B). 
However, in cells that were activated, similar memory behavior was observed as under anoxic 
conditions: unsorted memory cells were quickly diluted out (Figure 2.4E, A.6), while sorted memory 
cells grew in clonal populations for at least 8 d (~ 7 generations) (Figure A.8).  A viability assay using the 
dead cell stain Sytox Blue (Invitrogen) revealed that memory cells remained less viable than non-
memory cells 1 d post-hypoxic exposure: (15.9% death versus 1.68% death, respectively), as compared 
to MD10/TetOx2 memory and non-memory cells (Figure 2.4F). This difference in viability contributed 
not only to dilution of the memory population over time, but was also indicative of memory and non-
memory subpopulations having distinct biological responses to hypoxia. 
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 To investigate these responses, we first established that endogenous pathways responsive to low 
O2 concentrations were similarly functional in MD15/HRE and its background strain. Both cell lines 
were exposed to hypoxia, and HIF target gene expression was measured by real-time PCR (Figure 2.4G) 
(Ke and Costa 2006). Since gene activation patterns were similar in both cell lines, we concluded that 
MD15/HRE responded to hypoxia with normal gene regulation. While this experiment examined 
hypoxic responses of the population as a whole, we next assessed whether expression of target genes was 
specifically up-regulated in memory cells, as compared to non-memory cells. Since memory cells had 
surpassed the circuit’s bistable threshold for loop expression, they were expected to have responded 
more strongly to hypoxia. Memory and non-memory cells were sorted 1 d post-hypoxic exposure, and 
HIF target gene expression was compared by real-time PCR (Figure 2.4H). Indeed, we found that a 
subset of HIF target genes were up-regulated in memory cells. Some target genes were not up-regulated, 
which was likely due to the fact that exposed cells needed to recover for 1 d for fluorophores to develop, 
to allow for FACS analysis, during which time the initial transcriptional response to hypoxia subsided. 
Nevertheless, these results demonstrate that the synthetic circuit integrated in the cell line MD15/HRE 
is capable of sensing and tracking subpopulations that differ in their responses to hypoxia. 
 
An integrated DNA damage memory device 
To follow memory of DNA damage, the stable cell line MD12/p53R2-RE was generated via random 
genomic integration of the p53R2-RE trigger and loop as a single plasmid. While NCS was used as a 
DNA damaging agent in transient experiments, it was not amenable to long-term cell tracking due to its 
highly deleterious effects on cell viability. Alternatively, a brief burst of 10 J/m2 shortwave ultraviolet 
radiation (UV) allowed greater cell viability (Latonen, Taya, and Laiho 2001; Sharma et al. 2010). UV 
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exposure resulted in trigger and loop activation in 20.2% and 8.3% of cells, respectively, as determined 
by FACS (Figure 2.5A), and higher trigger activation corresponded to greater loop activation (Figure 
A.5C); this behavior was similar between all positive selected clones (Figure A.9). Fluorescence 
microscopy indicated that memory persisted for at least 2 d post-exposure within a subpopulation of 
cells (Figure 2.5B), however, a significant decrease in the percentage of cells expressing the loop was 
observed during the first 2 d post-exposure. 
While this characteristic precluded FACS analysis of sustained memory, fluorescence 
microscopy revealed that loop expression was maintained in small clonal populations when memory 
cells were isolated 2 d post-UV exposure (Figure 2.5B, A.6). The loop was expressed in a subpopulation 
of cells for at least 10 d (~ 8 generations) post-sort. This indicated that a subpopulation successfully 
activated the device above the bistable threshold for loop expression, permitting tracking of memory and 
non-memory cells. Gene dysfunction was not a contributing factor to the observed memory population 
decrease, as sorted non-memory cells were able to re-induce both the trigger and loop to levels 
comparable to their initial induction (Figure 2.5C). Furthermore, epigenetic silencing of the device did 
not likely affect its function over time: exposure to TSA alone caused no significant induction of the 
device, and pre-treatment with TSA did not increase the number of cells that responded to subsequent 
UV exposure (Figure 2.5D). 
 These results implied that the proportion of memory cells — having executed a stronger 
DNA damage response — decreased post-damage due to a growth defect or cell death, resulting in 
dilution of the population over time by the more rapidly growing or viable non-memory cells. When 
equal numbers of sorted memory and non-memory cells were plated and observed for 4 d by  
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Figure 2.5. MD12/p53R2-RE device identifies a subpopulation with unique memory of DNA damage.  
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Figure 2.5 (continued). MD12/p53R2-RE device identifies a subpopulation with unique memory of 
DNA damage. (A) Cells were exposed to UV and tracked by FACS for 2 d. (B) Cells were exposed to 
UV and recovered for 1d. Memory cells (YFP+) were sorted and followed by microscopy for 10 d. (C) 
Cells were exposed to UV and recovered for 1d. Non-memory cells were sorted and re-exposed to UV 5 
d post-sort. (D) Cells were exposed to dox, TSA, or TSA+UV to identify epigenetic silencing of the 
device. (A,C,D) FACS determined % cells positive for trigger RFP and loop YFP. Values represent mean 
± SE, n = 3. (E) Cells were exposed to UV and recovered for 2 d. Cell death was measured in memory 
versus non-memory cells by FACS. Values represent mean ± SE, n = 3. (G) MD12/p53R2-RE and 
U2OS cells were exposed to UV, and p53 target gene expression was measured. Values represent mean 
fold expression change over unexposed cells ± SE, n = 3. (H) Cells were exposed to UV and recovered 
for 1 d. Memory and non-memory cells were sorted, and p53 target gene expression was measured in 
each subpopulation. Values represent mean fold expression change in memory versus non-memory cells 
± SE, n = 2. 
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fluorescence microscopy, non-memory cells reached confluency 2 d sooner than memory cells (Figure 
A.7C). This slow growth phenotype could account for memory cells being diluted out of the population 
over time when memory and non-memory cells are grown together. Using the dead cell stain Sytox Blue, 
we also determined thatmemory cells were less viable than non-memory cells 2 d post-UV exposure: 
8.4% cell death versus 0.8%, respectively (Figure 2.5E). All together, these data suggest that memory 
cells maintained distinct growth and viability phenotypes after UV exposure. 
 We next asked whether unique gene expression profiles characterized how distinct 
subpopulations responded initially to DNA damage. Endogenous response pathways were similarly 
functional in MD12/p53R2-RE and its background strain post-UV exposure, as measured by p53 target 
gene expression using real-time PCR (Figure 2.5F) (Brady and Attardi 2010). Furthermore, a subset of 
target genes was specifically up-regulated in memory cells (Figure 2.5G). Memory and non-memory 
subpopulations were sorted 1 d post-UV exposure, and p53 target gene expression was compared by 
real-time PCR. Since exposed cells required 1 d of recovery before sorting, not all target genes were up-
regulated at the indicated time-point. In sum, these results verify that the synthetic circuit is capable of 
differentiating between subpopulations that uniquely respond to DNA damage.   
 To assess whether specific initial responses translated into each subpopulation maintaining 
distinct long-term expression profiles, we performed gene expression profiling of memory and non-
memory cells multiple days after UV exposure. After 3 d of recovery from UV treatment, memory and 
non-memory cells were sorted. The expression signature of memory cells was distinct from their non-
memory counterparts: 127 genes were up-regulated and 31 were down-regulated in memory cells (fold 
change ≥ 2.0, corrected P-value ≤ 0.05) (File A.2). Bioinformatics analysis identified the transcriptional 
pattern of oxidative stress in memory cells (Figure 2.6A): up-regulated genes were enriched for those 
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responsive to external stimulus (P = 1.48e-03), wounding (P = 1.56e-03), hydrogen peroxide (P = 
3.41e-03), stress (P = 3.89e-03), reactive oxygen species (ROS) (P = 6.05e-03), and chemical stimulus 
(P = 9.29e-03). Enrichments were validated by real-time PCR (Figure A.10A). To eliminate any 
background effect of expression of a synthetic device, transcriptional profiling of MD10/TetOx2 sorted 
memory versus non-memory cells was also performed and up-regulated genes were removed from the 
MD12/p53R2-RE data analysis (Figure A.10B, File A.2).  
While the microarray data defined a set of genes that were uniquely expressed in memory cells 
multiple days post-DNA damage, it does not inform upon the expression level of those genes at earlier 
time-points. To address this question, we tested the expression of 4 up-regulated genes - CDNF, MXD1, 
SCL39A2, and GRK5 – 1 d after UV exposure. Interestingly, all four tested genes showed significant up-
regulation in YFP+ cells, as compared to YFP- cells. Thus, these genes were expressed both 1 d and 3 d 
after UV exposure. This suggested UV-mediated DNA damage produced a transcriptional response that 
was maintained over time in memory and non-memory cells. Since differences not only in gene 
expression, but also viability and growth, were shown to persist for multiple days, we concluded that the 
MD12/p53R2-RE circuit is capable of capturing subpopulations with distinct long-term memories to 
DNA damage.  
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Figure 2.6. MD12/p53R2-RE device identifies a subpopulation with a unique transcriptional profile. 
(A) Gene ontology enrichment of genes up-regulated in memory cells 3 d post-UV exposure. (B) Cells 
were exposed to UV and recovered for 1 d. Memory and non-memory cells were sorted and gene 
expression was measured in each subpopulation. Values represent mean fold expression change in 
memory versus non-memory cells ± SE, n = 2.  
 
Discussion 
Building a prototype memory circuit in mammalian cells 
In this study, we present the successful engineering and implementation of synthetic memory devices in 
human cells. The construction of a prototype, dox-inducible circuit (MD10/TetOx2) revealed 
behavioral qualities of an integrated, transcription-based device that could inform further applied 
systems. In all isolated clones, most cells activated the trigger in response to dox, and a significant 
fraction activated the memory loop. Moreover, a subpopulation of loop-expressing cells transmitted the 
memory protein to daughter cells for multiple generations. These cells likely activated the circuit above 
its bistable threshold. The MD10/TetOx2 circuit provides one of the first synthetic examples of what is 
required to create a bistable mammalian memory switch based on positive feedback.  
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  While a significant percentage of cells maintained loop expression post-exposure, this 
population decreased over time. Indeed, time-lapse fluorescence microscopy revealed that some 
daughter cells failed to inherit memory protein from loop-expressing mother cells. As this was observed 
for all selected clones, the genomic integration location was unlikely to be causative. However, we 
hypothesize that epigenetic silencing resulted in memory loop deactivation, and stochastic noise in 
memory loop protein segregation during cell division might also have played a role. If a daughter cell 
randomly fails to receive a sufficient amount of loop protein to maintain feedback, it will switch to a 
non-memory state that is propagated in future progeny. This behavior has been observed for both 
natural and synthetic transcriptional auto-regulatory circuits (Becskei, Séraphin, and Serrano 2001; 
Weinberger and Shenk 2007; To and Maheshri 2010). Producing more loop protein before cell 
division, either by increasing the synthesis rate or reducing the rate of cell division, is expected to 
minimize any loss of memory over time (Ajo-Franklin et al. 2007). However, for certain uses — such as 
drug dosage in a clinical setting — short-term memory loop expression could be desirable. Indeed, 
exploring the tunability of our memory system could help define any constraints on the device’s 
potential applications. 
 
Integrating synthetic circuits with endogenous pathways 
To demonstrate its further potential to report on biological phenomena, the MD10/TetOx2 device was 
reconfigured to respond to endogenous hypoxia and DNA damage response pathways. Memory cells 
were identified as descendents of cells that experienced HIF-1 or p53R2 activity above the circuit’s 
bistable threshold, while non-memory cells were those that responded more weakly such that the loop 
was not activated. The formation and defining characteristics of these memory cells, versus their non-
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memory counterparts, could vary depending on cell state, DNA damaging or hypoxic agents, length of 
exposure, and time of recovery. Furthermore, a given stressor likely produces many subpopulations with 
uniquely protracted responses. Our goal was to use the described circuits to identify how an initial 
response translated into sustained biological characteristics that distinguished what we defined as 
memory and non-memory cell subpopulations.  
 Interestingly, the DNA damage and hypoxia memory devices behaved quite differently from the 
dox memory device. MD10/TetOx2 responded to dox by activating the trigger to similar levels in all 
cells and the memory loop to similar levels in approximately 43% of cells (Figure A.2). In contrast, 
MD15/HRE and MD12/p53R2-RE responded to hypoxia and DNA damage, respectively, with largely 
variable activation of the trigger and loop in a smaller percentage of cells (Figure A.5). Furthermore, 
while memory of dox exposure was sustained in a significant number of cells, memory of hypoxia and 
DNA damage persisted in a small subset.  
 Behavioral differences were likely due to the more heterogeneous activation of hypoxia and 
DNA damage signaling pathways. MD10/TetOx2 induction occurs when the tet-repressor can no 
longer bind the trigger’s promoter due to the presence of dox, resulting in strong, homogeneous trigger 
expression (Figure A.2). In contrast, MD12/p53R2-RE and MD15/HRE activation is dependent on 
signals transduced by biological pathways composed of numerous proteins, each with its own degree of 
biological noise affecting its behavior. Unlike the dox-inducible trigger, HIF-1 and p53 should not be 
uniformly activated within a population (Bristow and Hill 2008; Murray-Zmijewski, Slee, and X. Lu 
2008), resulting in heterogeneous trigger and memory loop activation (Figure A.5). MD15/HRE and 
MD12/p53R2-RE thus permit the isolation of two distinct subpopulations post-hypoxia or damage.  
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 The utility of the hypoxia and DNA damage memory devices to detect biologically unique 
populations was assessed in multiple ways. We determined in initial response to hypoxia or UV, HIF and 
p53 target gene expression was elevated in MD15/HRE and MD12/p53R2-RE cells that activated both 
the trigger and loop, as compared to cells that only activated the trigger. This result indicated that the 
devices work as intended: cells with a stronger response are capable of overcoming the bistable 
threshold of the circuit, such that the loop is expressed. We also established that a stronger response 
translated into long-term phenotypes, including slow growth and poor viability. Memory cells exhibited 
these characteristics for multiple generations past the point of exposure, as compared to their non-
memory counterparts.  
 Finally, gene expression profiling of revealed that DNA damaged memory cells had a persistent 
gene expression signature that was entirely different from that of non-memory cells and was maintained 
over time. The memory cell expression profile was largely enriched for genes responsive to oxidative 
stress, as well as stress in general, including DNA-damage-inducible transcript (DDIT3), glutathione 
peroxidase 3 (GPX3), MAX dimerization protein 1 (MXD1), egl nine homolog 3 (EGLN3), and tumor 
protein p53 inducible nuclear protein 1 (TP53INP1). UV radiation is known to cause significant 
intracellular production of ROS and reactive nitrogen species, as well as alter the levels of intracellular 
antioxidant enzymes (Zhang et al. 1997; Birch-Machin and Swalwell 2010). Our study shows that 
transcriptional responses to UV-induced oxidative damage persist through multiple generations in a 
subpopulation of cells. It is possible that this differential maintenance of gene expression translates into 
differences in vulnerability to future damage or aging, and may also dictate the mechanisms by which 
each subpopulation protects the fate of its progeny. 
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Conclusions 
The memory devices presented here have the potential to illuminate previously undescribed biological 
phenomena. The DNA damage and hypoxia memory circuits could be utilized in further analyses — 
such as deep-sequencing or epigenetic mapping — of differentially-responsive populations, to create a 
more detailed picture of how a cell’s history contributes to its biological future. Differentially regulated 
genes in memory cells could potentially serve as targets in future work toward defining how the inherited 
expression profile is maintained. This  approach could implicate genes that play a role in disease 
development. The work might also be translated to a xenograft model in mice to study the in vivo 
heterogeneous effects of DNA damage and hypoxia through the development of a solid tumor. It would 
be interesting to identify whether these transient stimuli produce subpopulations that are more or less 
prone to disease development. Given their modular nature, the circuits could potentially produce 
outputs other than fluorophores. For example, once a memory device is proven safe for patients, it could 
possibly be used in a clinical setting by modifying the loop to produce a therapeutic drug in response to a 
transient stimulus. The loop could also be altered to create a useful tissue engineering tool that produces 
morphogens or growth factors for differentiation control in tissue engineering applications. While these 
proposed ventures will require significant re-tooling and testing of the device, their pursuit will help 
advance and challenge the utility of synthetic circuits. 
 Our work demonstrates that complex biological problems can be investigated with an synthetic 
devices. To date, development of new synthetic devices has been hindered by a slow design cycle and 
poor device robustness, particularly in mammalian cell culture (Burrill, Boyle, and Silver 2011). 
Streamlining the mammalian design cycle is critical as synthetic biology strives to better integrate with 
complex human applications such as stem cell therapy and tissue engineering. Building more complex 
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mammalian devices will undoubtedly provide invaluable data for more comprehensive quantitative 
models, which will allow better predictions of function at the preliminary design stage and thereby 
reduce the number of tested iterations of a device. Synthetic devices destined for clinical applications 
must also demonstrate faithful performance; constructing genomically integrated devices, as with our 
memory devices, is an important first step. Improving mammalian cell design remains an essential task 
for synthetic biology, as the field continues to engage in the engineering of increasingly complex cell 
types. 
 
Materials and Methods 
Plasmid constructs 
Escherichia coli DH5α was used for all plasmid manipulations. Bacteria were grown in LB-ampicillin 
media to maintain plasmids; if engineered constructs contained synthetic zinc fingers, media was 
supplemented with 0.02 mM zinc chloride. DNA fragments with universal cloning sites (EcoRI, NotI, 
XbaI, SpeI, and PstI) were generated by PCR and assembled via BioBrick DNA assembly (Phillips and 
Silver 2006). 
 A CMV-TetOx2 promoter fragment (from pcDNA5/FRT/TO©, Invitrogen) ligated in front of 
a human kozak sequence produced a doxycycline (dox)-inducible promoter. HRE promoter was 
provided by the Brown lab (Shibata, Giaccia, and Brown 2000). Response elements from human p53R2 
gene (Ohno et al. 2008) were constructed as annealed oligos (Integrated DNA Technologies) and 
ligated in front a minimal promoter (Shibata, Giaccia, and Brown 2000) to generate p53R2-RE 
promoter. Human codon-optimized synthetic zinc fingers (Hurt et al. 2003) were commercially 
synthesized by Mr. Gene (Regensburg, Germany).  
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 For transient transfections, triggers and reporters were cloned as NotI/SpeI fragments into the 
Flp-In™ T-REx™ vector in which the promoter was deleted (Invitrogen, Silver Lab). For 
MD10/TetOx2 (clone MD10.21), trigger and memory loop genes were cloned as separate fragments 
into a pcDNA3.1™ (+)-based vector (Invitrogen) in which the neomycin resistance marker was 
replaced with hygromycin or puromycin resistance, respectively, and the constitutive CMV promoter 
was deleted (Silver Lab). For MD12/p53R2-RE (clone MD12.34) and MD15/HRE (clone MD15.21), 
trigger and loop genes were cloned as one fragment into the puromycin-resistant pcDNA3.1™ (+)-
based vector (Invitrogen, Silver Lab). 
 
Memory device design strategy 
Devices were built in two stages. First, multiple gene circuits were designed and tested via transient 
transfection. In these plasmid-based experiments, multiple designs were characterized to identify 
elements that generated the most effective circuit activation and least basal activity. Selected prototypes 
were then genomically-integrated to produce the final stable devices that are characterized in greater 
detail in this work. 
 
Cell culture and transfection 
Plain U2OS and U2OS Flp-In™ T-REx™ cells (Blacklow Lab) were grown in McCoy’s 5A medium 
supplemented with 10% tetracycline-screened fetal bovine serum (FBS) and 1% penicillin and 
streptomycin; T-REx™ cells were further supplemented with 15 ug/mL blasticidin and 200 ug/mL 
zeocin. Cells were grown at 37˚C in a humidified CO2 incubator.  
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 Transient transfections were performed by plating 1.2 X 105 cells/well in 12-well culture dishes 
and transfecting with 800 ng total plasmid DNA and 2 ul Lipofectamine® 2000 (Invitrogen) in 1 ml of 
antibiotic-free medium (Table A.1). Media was changed 4 h post-transfection and cells were exposed 20 
h later to 1 ug/mL dox (Sigma-Aldrich), 0.5 ug/mL neocarzinostatin (NCS) (Sigma-Aldrich), or 100 
μM cobalt chloride (CoCl2) (Sigma-Aldrich) for 24 h and analyzed by fluorescence activated cell sorting 
(FACS).   
 Stable cell lines were generated by plating 3.0 X 105 cells/well in 6-well culture dishes and 
transfecting with 2 ug plasmid DNA and 5 ul Lipofectamine®  2000 in 2 mL of antibiotic-free medium. 
Media was changed 4 h post-transfection and cells were exposed to selection media the following day 
(Table A.2). After 5 d of selection, media was changed to maintenance antibiotic concentrations (Table 
A.2). Clones were picked and screened for inducible expression via 1 ug/mL dox, 0.5 ug/mL NCS or 
100 μM CoCl2. Positive clones were expanded and maintained as stable lines. 
 
Induction of MD12/p53R2-RE and MD15/HRE cell lines 
To analyze MD12/p53R2-RE behavior, 3.0 x 105 cells/well were plated in 6-well plates. The following 
day, plates were exposed to a brief burst of 10 J/m2  shortwave ultraviolet radiation (UV) (Lahav Lab, 
Harvard Systems Biology). To analyze MD15/HRE behavior, 3.0 x 106 cells were plated in 10 cm plates. 
The following day, plates were exposed to anoxia (0% O2, ~2.0% H2) in an anaerobic chamber (Wyss 
Institute for Biologically Inspired Engineering) for 1 d in CO2-independent media (Invitrogen) or 
hypoxia (0.1% O2, 5.0% CO2) in a hypoxic chamber (Kaelin lab, Dana Farber Cancer Institute). When 
cells were returned to normoxia, media was replaced with appropriate maintenance media. 
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Flow cytometry and cell sorting 
Prior to FACS analysis, cells were fixed in 4% paraformaldehyde/1x PBS solution for 10 min, 
resuspended in 200 uL of 1x PBS, and stored at 4˚C. Cells were later loaded in 96 well plates or 5 mL 
polystyrene tubes (BD Biosciences) on an LSRII (BD Biosciences) with 488-nm (DsRed) and 568-nm 
(Fitc) lasers (Harvard Systems Biology). 1.0 X 104 cells were analyzed for RFP (DsRed) and YFP 
(FITC) fluorescence and gated based on cell size and granularity. Unexposed cells controlled for basal 
fluorophore expression. Data was analyzed using FlowJo software. 
 To sort MD10/TetOx2 cells, 3, 6-well plates were exposed to dox, washed with 1x PBS, and 
moved to 3, T-150 flasks for 2 d. Cells were then trypsinized, spun at 1100 rpm for 5 min, washed with 
1x PBS, spun a second time, resuspended in 3 mL of 1x PBS/1% FBS, and filtered. To sort 
MD12/p53R2-RE cells, 12, 6-well plates were exposed to UV and recovered for 2 d. Cells were then 
processed as described above, except that 4, 6-well plates of cells were pooled to produce three 
replicates. To sort MD15/HRE cells, 9, 10 cm plates were exposed to anoxia or hypoxia and recovered 
for 1 d. Cells were then processed as described above, except that 3, 10cm plates were pooled to produce 
three replicates.  
Processed cells were run on a FACS Aria II with a 100 uM nozzle at 20 psi (Harvard Systems 
Biology). Excitation optics for RFP consisted of a 75 mW 594 nm laser; detection optics included a 
630/22 bandpass filter. Excitation optics for YFP consisted of a 15 mW 488 nm laser; detection optics 
included a 520 nm longpass dichroic mirror and a 530/30 bandpass filter. For microscopy, 200,000 
memory and non-memory cells were sorted. Sorted MD10/TetOx2 and sorted MD15/HRE cells were 
seeded in 12-well dishes; sorted MD12/p53R2-RE cells were seeded in 24-well dishes. 
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Fluorescence microscopy 
For short-term microscopy, cells were imaged at 20x with a Nikon TE2000-E inverted fluorescence 
microscope equipped with a Hamamatsu ORCA-ER camera, and HcRed (RFP) and JP2 (YFP) filters 
(Silver Lab). Images were acquired and analyzed using Metamorph software.  
 For long-term imaging, 5.0 X 104 cells/well were seeded in a 12-well glass-bottom culture dish 
(MatTek) and exposed to dox for 1 d. Wells were next washed with media. Cells were allowed to recover 
for 1 d and then imaged every hour for 3 d using a Plan Apo 20x 0.75 NA objective lens on a Nikon 
TE200E motorized inverted microscope equipped with a Hamamatsu ORCA-ER cooled CCD camera, 
Prior Proscan II motorized stage and shutters, EXFO X-cite 120-XL fluorescence illuminator, a 37˚C, 
5% CO2 custom-built microscope enclosure incubation chamber, and mCherry (RFP) and YFP filter 
sets (Nikon Imaging Center, Harvard Medical School). Images were acquired and analyzed using 
Metamorph software.  
 
Cycloheximide assay 
MD10/TetOx2 cells were plated in 12-well dishes and exposed to dox in triplicate. After 24 h 
incubation, cells were exposed to 100 uM cycloheximide (CHX) (Sigma-Aldrich) for 8 h. 3 wells were 
fixed in 4% PFA / 1x PBS per hour and later analyzed by FACS. Same procedure was applied to regular 
T-REx™ cells.  
 
Histone deacetylase inhibitor assay 
MD10/TetOx2 cells were plated in 12-well dishes, MD12/p53R2-RE were plated in 6-well dishes, and 
MD15/HRE were plated in 10 cm plates. Cells were exposed in triplicate to 50 ng/mL trichostatin A 
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(TSA) (Sigma-Aldrich) for 16 h, and then washed and exposed in triplicate to dox, UV, or anoxia. 3 
wells were fixed in 4% PFA / 1x PBS and later analyzed by FACS. 
 
Sytox Blue assay 
MD15/HRE cells were plated in 10 cm plates, exposed to hypoxia, and recovered for 1 d. 
MD10/TetOx2 cells were plated in 6-well plates, exposed to dox, and recovered for 1 d. MD12/p53R2-
RE cells were plated in 6-well plates, exposed to UV, and recovered for 2 d. To analyze viability, cells 
were trypsinized, spun at 1100 rpm for 5 min and resuspended in 10 mL 1x PBS. 500 uL from each plate 
was stained with 1 uM Sytox Blue Dead Cell Stain (Invitrogen), incubated for 5 min, and analyzed by 
FACS using the AmCyan filter. Unexposed cells were similarly to treated to control for basal levels of 
cell death.  
 
Endogenous pathway induction 
MD12/p53R2-RE and MD15/HRE were plated and exposed to UV or hypoxia, respectively. Whole cell 
RNA was extracted using the RNeasy Mini Kit (Qiagen), and cDNA was prepared using the SuperScript 
III First Strand Synthesis System (Invitrogen). Unexposed cells served as controls for background 
expression. 
 
Gene expression profiling 
MD10/TetOx2 and MD12/p53R2-RE cells were plated in 6-well plates, exposed to dox or UV in 
triplicate, respectively, and allowed to recover for 3 d. Cells were then processed as described above for 
cell sorting. For each biological replicate, 200,000 memory and non-memory cells were sorted and RNA 
was extracted using the RNeasy Mini Kit (Qiagen). cDNA was prepared, biotinylated, and hybridized to 
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Gene 1.0 ST arrays (Affymetrix). Arrays were scanned and quantified according to standard Affymetrix 
protocols at the Dana Farber Microarray Core Facility (Dana Farber Cancer Institute). Datasets have 
been submitted to the GEO database, record XXXXXX. 
 
Identification and analysis of differentially regulated genes 
Data was annotated and normalized by RMA-analysis using Affymetrix Expression Console Software.  
Differential gene expression was determined using the Matlab Bioinformatics Toolbox (MathWorks). P-
values were calculated using a permutation t-test of 10,000 permutations. Genes with a fold change ≥ 2 
and p-value ≤ 0.05 were considered differentially expressed and analyzed for gene ontology enrichment 
via GoStat (http://gostat.wehi.edu.au), with Benjamini correction for multiple hypothesis testing; 
enrichment was considered significant with P ≤ 0.01. Differentially expressed genes were validated by 
real-time PCR using 0.5 ug RNA of specified cell populations. Primers amplified ~ 100 base pairs (Table 
A.3). Differential expression was normalized to human gene ACTB. 
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Chapter 3 
 
 
 
 
 
Studying memory of cellular stresses in human cells 
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Abstract1 
Heterogeneous and long-term responses to transient cellular stimuli may underlie various 
developmental and disease processes. In particular, the heterogeneous nature of the cellular response to 
exogenous stresses makes these processes difficult to study in a large population of cells. Transcriptional 
memory devices, such as those discussed earlier in Chapter 2, allow us to isolate differentially 
responding subpopulations after exposure to hypoxia, DNA damage, and other stressors. In this 
Chapter, we discuss the study of long-term effects of hypoxic exposure demonstrating the necessity of a 
cellular memory device. We also explore the application of the DNA damage memory device to learn 
about the effects of γ-radiation exposure. Lastly, we modify the memory device to respond to 
inflammation via the NF-κB signaling pathway. Taken together, these studies show the modularity and 
broad usefulness of a cellular memory device. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Portions of this chapter were reproduced with permission from Cold Spring Harbor Laboratory Press: 
Burrill DR, Inniss MC, Boyle PM, Silver PA. 2012. Synthetic memory circuits for tracking human cell fate. Genes Dev 
26:1486–1497.	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Studying the long-term effects of transient hypoxic exposure in human cells 
 
Introduction 
The role of hypoxia in cancer initiation, progression and prognosis has been recognized for the past 70 
years. The observation by Otto Warburg that tumor cells seem to favor glycolysis over aerobic 
respiration for energy production, even in the presence of oxygen, first suggested the involvement of 
hypoxia or hypoxic adaptation in this disease(Warburg 1961). Hypoxic cells have since been 
demonstrated to be present in many solid tumors, correlating with a poor response to treatment and 
increased chance of metastasis(Chan and Giaccia 2007). Solid tumors grow rapidly and outstrip their 
blood supply resulting in hypoxic conditions when cells are beyond the diffusion limit of 
oxygen(Teicher 1994). In addition, the new vessels formed by angiogenesis are often poorly formed and 
do not provide a consistent supply of oxygen and nutrients leading to cycling hypoxia(Cárdenas-Navia 
et al. 2008). 
 It has been shown that hypoxia can influence mutation rates in mammalian cells(Bristow and Hill 
2008). Hypoxia and reoxygenation can cause oxidative stress that in turn can cause DNA damage. It is 
hypothesized that this could result in the accumulation of mutations that may drive tumor progression 
and metastasis(Bristow and Hill 2008). Recent studies have shown that acute, cycling hypoxia early in 
tumor development may result in a larger number of metastases later on(Bindra, Crosby, and Glazer 
2007). In some cancer models, hypoxia appears to increase the amount of 8-oxo-dG (associated with 
GC-AT transitions) but has little effect on metastatic development, while in another cancer model, mice 
exposed to hypoxia show less 8-oxo-dG lesions but increased incidence of metastases(Bindra, Crosby, 
and Glazer 2007). This indicates that the relationship between hypoxia, DNA damage and metastasis is 
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more complicated than originally believed. 
 Aside from potentially causing DNA damage due to oxygen deprivation and reoxygenation, 
hypoxia has been proposed to impose epigenetic marks on cancer cells(Chen et al. 2006; Shahrzad et al. 
2007; Lee et al. 2009; Watson et al. 2009).  These changes in gene expression can be the result of 
chromatin modifications(Kouzarides 2007) or changes in transcriptional profile. Microarray studies 
have shown that numerous genes are differentially regulated as a result of hypoxic exposure, many of 
which are involved in pathways regulating cell proliferation, cell division and apoptosis(Fredlund et al. 
2008). In addition, it has been demonstrated that in the case of RUNX3, a gene often silenced in gastric 
cancer, exposure to hypoxia results in histone modification, specifically histone deacetylation and 
methylation of H3K9(Lee et al. 2009). We propose to study whether other genes down regulated by 
hypoxia are subject to histone modifications or promoter hypermethylation and whether these 
modifications are inherited through cell division.  
Microarray analysis will be used to look for genes that are differentially expressed due to 
exposure to hypoxia and whose expression remains changed once the cells have been reoxygenated. 
MCF10A cells will be exposed to hypoxia and allowed to recover in normal oxygen conditions for 
several days. RNA will be extracted from exposed cells and unexposed control cells that have been 
passaged at the same time.  Transcript levels will be probed using the Human Gene 1.0 chip 
(Affymetrix). Once a set of differentially expressed genes has been identified, we will investigate whether 
these changes are the result of chromatin modification, DNA methylation, or transcriptional regulation. 
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Results and discussion 
Preliminary characterization of hypoxic response 
To determine which cell line to use to look for long-term effects of hypoxic exposure on the 
transcriptional profile of cells, we first performed end-point PCR on a panel of candidate cell lines 
(MCF7, T47D, and MCF10A) to make sure they were responding as expected to hypoxia (Figure 3.1A-
C). Cells were exposed to 0.5% oxygen for 24 hours. RNA was then extracted and used to make cDNA. 
PCR was performed using primers for several known HIF-1 target genes. The product of these reactions 
was then analyzed by gel electrophoresis. We observed increased expression of CA-IX at 24 h relative to 
unexposed cells in all cell lines. We also observed moderately increased expression of VEGF and GLUT1 
at 24h in both MCF7 and MCF10A cells. While we did not observe long-term changes in these genes, 
we hypothesize that other genes may be affected. MCF7 and MCF10A are both cell lines derived from 
breast tissue. However, MCF7 is more representative of a cancer, while MCF10A is more “normal” cell 
type(Christofk et al. 2008). Based on this data, we decided to use MCF10A cells in further experiments, 
as our results would be more generalizable outside of a disease state. 
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Figure 3.1. Hypoxic exposure causes upregulation of hypoxia responsive genes.  
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Figure 3.1(continued). Hypoxic exposure causes upregulation of hypoxia responsive genes. Selected 
cell lines (MCF7, T47D, MCF10A) were exposed to 0.5% O2 for 24 hours and allowed to recover in 
normoxia. RNA was extracted, converted to cDNA, and end-point PCR was performed and results 
quantified by ImageJ (A-C). MCF10A was selected for further analysis. RNA from 24 h exposed, and 3 d 
recovered cells along with corresponding unexposed controls were submitted for microarray analysis. 
While expected patterns of gene upregulation were seen after 24 h exposure (D) no significant patterns 
were seen after 3 d recovery. 
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Microarray analysis of the long-term transcriptional response to hypoxia 
To investigate long-term transcriptional changes in response to hypoxic exposure, MCF10A cells were 
exposed to hypoxia (0.5% O2) for 24 hours and then allowed to recover in normoxia. RNA was extracted 
from hypoxic cells immediately after exposure as well as cells that had recovered for 3, 6, and 9 days. 
RNA was also extracted from unexposed cells that were passaged at the same time. RNA from the 
hypoxic and 3 day recovered cells was sent to the Dana Farber microarray core for processing for the 
Human Gene 1.0 ST array (File B.1). The data was annotated and normalized by RMA analysis using 
the Affymetrix Expression Console software. Differential gene expression was determined using the 
MATLAB Bioinformatics Toolbox (MathWorks) and P-values were calculated using a permutation t-
test of 10 000 permutations. Using a cutoff of fold change ≥ 2 and P-value ≤ 0.05, 79 genes were 
differentially regulated (66 up, 13 down). These genes were consistent with a typical response to low 
oxygen. However, using the same cutoffs, no genes were considered differentially regulated after 3 days 
recovery. When the fold change cutoff was relaxed to 1.5 fold, only 7 genes were differentially regulated 
(5 up, 2 down). Gene enrichment ontology analysis of the genes upregulated at 24 hours showed 
enrichment of expected hypoxia pathway genes (Figure 3.1D). 
Since it is known that cells can undergo lasting changes in gene expression and chromatin 
structure after hypoxic exposure, it may be possible that changes are occurring in a small subpopulation 
of cells. Microarray would most likely not be able to detect this signal over the background of unaffected 
cells. In future, the hypoxia memory device described earlier in Chapter 2 could be moved to a 
biologically relevant cell line such as MCF10A. We showed that this synthetic transcriptional circuit 
allows us to isolate a differentially responding subpopulation. This experiment could then be repeated, 
comparing memory and non-memory cells. 
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Conclusions 
While we did not observe a long-term transcriptional change due to hypoxic exposure by microarray 
analysis, previous work suggests that we might see a change in a subpopulation of cells. This result 
illustrates the advantage of using a synthetic memory device such as the one described in Chapter 2 of 
this work. Additionally, MCF10A may not be the appropriate cell line to use in this type of study. In 
future, we could engineer several cell lines with a hypoxia responsive memory device and analyze 
transcriptional changes using next-generation sequencing methods that can be more sensitive than 
microarray analysis. 
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Developing a γ-radiation sensing memory device in human cells 
 
Introduction 
One of the challenges present in manned space flight is mitigating the risk of exposure to high levels of 
radiation and its effect on human cell biology(Rizzo et al. 2012). In particular, astronauts are exposed to 
galactic cosmic rays (GCR) consisting of protons, helium nuclei, and high energy and charge (HZE) 
ions. While the immediate health implications of radiation encountered on earth are well studied, near 
and long-term consequences of GCR exposure are not yet understood(Hellweg and Baumstark-Khan 
2007). This uncertainty is one of many challenges that must be resolved before long-term interplanetary 
travel becomes feasible. Understanding the consequences of prolonged exposure to GCR will help 
develop appropriate measures to prevent negative effects. Moreover, it would be a major breakthrough 
to develop a therapeutic strategy to reverse space-travel related radiation damage. 
The effects of γ-radiation are often used as a proxy for GCR in estimating the impact of GCR on 
human health. Moderate doses of γ-radiation cause DNA damage and changes in gene expression, while 
higher doses increase the risk of developing cancer, and cause cell death leading to acute radiation 
syndrome (ARS), and tissue damage(Dörr and Meineke 2011). While the immediate impact of higher 
doses of γ-radiation is clear, the long-term consequences of both high and moderate exposure are more 
difficult to gauge. Similarly, the cellular response to GCR may depend greatly on the dose and fluence 
experienced. Additionally, it is not clear how to relate these data about γ-radiation to the potential health 
effects of GCR.  
The field of synthetic biology aims to engineer biological systems in a more predictable and 
rapid manner to solve previously intractable problems and perform novel functions. This encompasses 
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everything from designing new genetic circuits, to reengineering complex chemical pathways, or 
rebuilding entire genomes. In Chapter 2, we describe a synthetic memory device, that can isolate a 
differentially responding cell population that maintains memory of a given stimulus(Burrill et al. 2012). 
This memory device is modular and can be re-engineered to respond to a variety of inputs including, 
doxycycline, hypoxia (low-oxygen), and DNA damage (UV radiation). These devices allow us to isolate 
a biologically distinct supopulation of cells that maintain growth but show transcriptional differences for 
many days after exposure to hypoxia and DNA damage.  
 We propose using the DNA damage sensing memory device integrated in human cells to study the 
possible long-term effects of γ-radiation exposure. While this device has been characterized using 
genotoxic chemicals and UV radiation, it should also be activated by γ-radiation(Shen and Maki 2010). 
This would allow us to study the long-term effect of radiation on gene expression profile and phenotype 
of these cells. Future work could adapt the device to produce an output such as a therapeutic to attempt 
to mitigate the effect of DNA damage.  
 
Results and discussion 
Characterization of existing DNA damage memory device after γ-radiation exposure 
Previously, an integrated memory device responsive to the p53 repair response was built and 
characterized in U2OS cells using UV radiation (Chapter 2). This cell line was exposed to a range (from 
1 Gy to 12.5 Gy) of γ-radiation using a Ce source. To determine whether the engineered cell line was 
responding normally to γ-radiation we analyzed expression of p53 target genes by RT-PCR. We 
collected RNA at 24 and 72 hour time-points and performed qRT-PCR to determine whether 
expression of predicted targets is up-regulated as expected in this cell line (Figure 3.2A). Unexpectedly, 
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expression of target genes was upregulated most strongly after 72 hours.  
 The behavior of the memory device was next assessed by both fluorescence microscopy and flow 
cytometry over several days. As observed when cells were exposed to UV, the trigger was not activated in 
all cells and the level of response was heterogeneous, however, the time scale of the response to γ-
radiation was very different than UV (Figure 3.2B). While we observed a maximal response to UV 
exposure after 24 hours, at all exposure levels of γ-radiation, we observed the percent of responding cells 
increasing and reaching a maximum at 72 hours post-exposure. This tells us that the device is responding 
to p53 signaling in a similar manner to endogenous target genes. In addition, we observed a much 
smaller percentage of responding cells than when the same cell line was exposed to UV (see data 
presented in Chapter 2; Figure 2.5).  
 
Investigating memory of γ-radiation exposure 
To test whether expression of the memory device could still be maintained through cell division 
we exposed cells to γ-radiation and allowed them to recover for 72 hours. Based on previous data, we 
exposed the cells to 10 Gy γ-radiation as was the lowest dose tested that maximized response after 72 
hours. Memory and non-memory cells were sorted by FACS and cultured separately in order to observe 
“memory” behavior by fluorescence microscopy and flow cytometry. However, we determined that 
when cells are exposed to this level of radiation, the memory cells do not survive the sorting procedure. 
We then exposed cells to lower amounts of radiation (5 Gy) recovered for 5 days, sorted by FACS, and 
cultured memory and non-memory cells separately. Memory was observed for up to 10 days post-
sorting (Figure 3.2C). As with the DNA damage memory device described in Chapter 2, the memory  
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Figure 3.2. DNA damage cell line responds and remembers γ-radiation exposure. (A) The DNA 
damage memory cell line (MD12.34) described in Chapter 2 was exposed to γ-radiation (0, 7.5, 10, or 
12.5 Gy) and allowed to recover for 24 or 72 h. RNA was extracted and analyzed by RT-PCR in 
triplicate. (B) Cells exposed to γ-radiation and allowed to recover for 24, 72, or 120 h were analyzed by 
flow cytometry to determine activation of trigger and memory genes. (C) Cells exposed to 5 Gy γ-
radiation were allowed to recover for 5 d before cell sorting by FACS. Memory and non-memory 
(negative) cells were cultured for 10 d before imaging by fluorescence microscopy. 
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population grew much more slowly that the non-memory population indicating we most likely isolated a 
differentially responding subpopulation. 
  
Improving response of memory device to γ-radiation 
In an effort to improve responsiveness of the memory device to γ-radiation we constructed two alternate 
trigger constructs (Figure 3.3A), in parallel; the first based on the natural MDM2 promoter 
region(Batchelor et al. 2011), and the second built on a synthetic Gadd45-based promoter. Gadd45 was 
chosen as it is reported to be upregulated very quickly after γ-radiation exposure(Kastan et al. 1992). 
The synthetic promoter consists of six repeats of the p53 binding site from Gadd45 followed by a 
minimal CMV promoter(Shibata, Giaccia, and Brown 2000). As in the original device, both promoters 
drive transcription of an artificial transcription factor consisting of a synthetic zinc finger (ZF) DNA-
binding domain (Hurt et al. 2003), one copy of the red fluorescent protein (RFP) mCherry (Shaner et 
al. 2004), the VP64 activation domain (Beerli et al. 1998), and a nuclear localization sequence (NLS) 
(Kalderon et al. 1984). We transiently transfected these constructs along with the original p53R2-RE 
trigger into U2OS cells to compare their inducibility by γ-radiation. Cells were exposed to either 10 
J/m2 UV or 5Gy γ-radiation and allowed to recover for 1 d before analysis by flow cytometry. While 
both the MDM2 promoter and synthetic Gadd45 promoters respond to DNA damage in the form of 
UV and γ-radiation, the MDM2 promoter showed relatively higher activation by γ-radiation. However, 
the original synthetic p53R2 promoter is activated in a higher percentage of cells by both forms of 
radiation. Therefore, we decided to continue using the original device.  
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Figure 3.3. Synthetic and natural p53 responsive promoters are activated by γ-radiation. (A) Schematic 
comparing the new trigger genes to the original DNA damage memory device. The 3kb MDM2 
promoter or a synthetic promoter consisting of 6 repeats of the p53RE from the Gadd45 promoter 
region were cloned in place of the original p53R2RE promoter. (B) The responsiveness to γ-radiation 
was assayed by transient transfection of trigger constructs into U2OS cells. Cells were transfected, 
exposed the following day to γ and UV radiation, and analyzed by flow cytometry 24 h later.  
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Conclusions 
We have demonstrated that the DNA damage memory device can be used to detect more diverse types 
of stimuli than UV radiation as characterized in Chapter 2. We also demonstrated that the synthetic 
promoter used in previous work is actually quite sensitive. This shows that the memory device can have 
broad applicability for further studies. In future, we would like to move the DNA damage memory 
device to more biologically relevant cell types and continue to characterize its responsiveness to different 
stimuli. This synthetic device will help us gain a greater understanding of the long-term effects of 
transient exposure to multiple sources of DNA damage. 
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Development of an inflammation responsive memory device 
 
Introduction 
Human disease pathology is complex, involving multiple tissues and organs(Huh et al. 2012). While 
traditional 2D cell culture systems have been integral in uncovering the architecture of many cellular 
signaling pathways, these systems are not representative of normal physiology(Huh, Hamilton, and 
Ingber 2011). For instance, in the context of drug discovery, these culture systems are used for initial 
screening of drug candidates. Animal studies are then needed to understand the effect of these drug 
candidates on whole organisms. However, even the best animal model is not a perfect substitute for 
human physiology and many drugs fail in clinical trials(Huh et al. 2012). Significant progress has been 
made developing 3D culture systems that more closely mimic the natural environment. As these systems 
incorporate human cells, they have the potential to become even more useful in the drug development 
process than animal models. The combination of novel 3D cell culture systems and synthetic memory 
devices presents an opportunity to gain an even greater understanding of underlying biology and 
develop a more refined drug discovery platform. 
Type 2 diabetes is a complex disease characterized by elevated blood glucose as a result of 
insulin insensitivity(Novials, Montane, and Cadavez-Trigo 2014). This disease also involves an 
inflammatory response along with oxidative stress and endoplasmic reticulum (ER) stress which can 
eventually lead to a loss of beta cell function and cell death(Novials, Montane, and Cadavez-Trigo 
2014). The NF-κB signaling pathway is central to the cellular response to all these triggers. NF-κB family 
transcription factors integrate signal from inflammatory cytokines and metabolic stress (including 
hyperglycemia), impacting further inflammation, cell survival, immunity, and metabolic 
pathways(Tornatore et al. 2012). By modifying the DNA damage memory device described earlier to 
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respond to NF-κB signaling, we can create a synthetic memory device that responds to inflammation 
and cellular stress in general. Such a device will help us learn about long-term cellular responses to 
inflammation and stress in a diabetes model. By integrating engineered cells into a 3D culture system, we 
can also help detect stress responses after drug treatment, thus enabling more effective drug 
development. 
We propose to move the existing DNA damage memory device along with a newly developed 
inflammation sensing memory device into beta cells to use in a novel drug discovery platform. Initially, 
these devices will be characterized in the immortalized insulinoma cell line βTC-6(Poitout et al. 1995), 
but will eventually be integrated in primary rat islet cells and human iPS cells. These synthetic circuits 
will allow us to gain a deeper understanding of biology of a complex disease like diabetes and could 
enable more sensitive screening of potential drug candidates. 
 
Results and discussion 
Design of an inflammation sensing memory device 
To develop an inflammation sensing memory device, we used a similar strategy as described in Chapter 
2 for building the hypoxia and DNA damage responsive devices. As we previously demonstrated the 
modularity of the memory device, it should be possible to modify the promoter of the trigger gene to be 
activated by an endogenous inflammation responsive pathway. We chose to couple memory to 
activation of NF-κB, as this signaling pathway is central to inflammatory responses as well as a general 
stress response pathway(Tornatore et al. 2012). To build a synthetic NF-κB responsive promoter, we 
chose to put several repeats of known NF-κB response elements (NRE) from the IL-1β gene(Hiscott et 
al. 1993; Cogswell et al. 1994) or the pNiFty3 promoter (Invitrogen) upstream of a minimal CMV 
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promoter(Shibata, Giaccia, and Brown 2000) (Figure 3.4A). This promoter mirrors the structure of the 
original DNA damage responsive promoter. We built four variants of this promoter by using one of two 
NREs and one of two spacings between NREs in each (Table 3.1). The four promoters were cloned 
upstream of the same artificial transcription factor described earlier, consisting of a synthetic zinc finger 
(ZF) DNA-binding domain (Hurt et al. 2003), one copy of the red fluorescent protein (RFP) mCherry 
(Shaner et al. 2004), the VP64 activation domain (Beerli et al. 1998), and a nuclear localization 
sequence (NLS) (Kalderon et al. 1984). 
 
Table 3.1. Synthetic NF-κB responsive promoter elements. 
Promoter NRE Variant Spacer Length Variant Sequence 
NRE1 A 24 bp 
A: GGGAAAATCC 
NRE2 A 12 bp 
NRE3 B 24 bp 
B: GGGACTTTCC 
NRE4 B 12 bp 
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Figure 3.4. Synthetic NF-κB responsive promoter responds to inflammatory stimulus. (A) Schematic 
comparing the new trigger genes to the original DNA damage memory device. A synthetic promoter 
consisting of 6 repeats of the NFκB response element from the IL-1β promoter region or the pNiFty3 
vector upstream of the minimal CMV promoter was cloned in place of the original p53R2RE promoter. 
(B) Responsiveness to inflammation-like stimuli was assayed by transient transfection of trigger 
constructs into βTC-6 cells. Cells were transfected, exposed the following day to LPC and IL-1β, and 
analyzed by flow cytometry 24 h later. 
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Characterization of NF-κB responsive trigger genes 
We next tested these novel trigger genes by transient transfection. As we are interested in using this 
device to study inflammatory responses of beta cells in response to drug treatment, we first characterized 
these constructs in a insulinoma cell line; βTC-6.  Cells were plated in 12-well plates and allowed to 
adhere overnight. Cells were transfected and the following day, they were exposed to LPC 
(lipopolysaccharide, 20 μg/mL; PMA, 10 ng/mL; db cAMP, 100 μM) or IL-1β (0.1 μg/mL).  Three of 
the four triggers showed little or no expression in response to these stimuli; however, the fourth 
construct was induced by IL-1β (Figure 3.4B). Expression was also seen after LPC treatment, however 
levels of activation were comparable to an uninduced control. Thus these preliminary results suggest 
that we have successfully built an NF-κB responsive trigger gene that may allow us to study long-term 
effects of inflammatory responses in human cells. Work is ongoing to refine this trigger gene, assemble a 
complete memory device, and integrate this into the genome. In addition, this circuit, along with the 
DNA damage memory device, will be tested in primary rat beta cells as well as iPS cells. 
 
Conclusions 
While we did not assemble the whole inflammation sensing memory device, we have preliminary results 
showing that we can create a synthetic NF-κB responsive trigger gene. Future work will refine this 
promoter and combine the trigger gene with the memory loop gene before integrating these constructs 
into the genome of βTC-6 cells as well as primary rat islet cells and human iPS cells. This will create a 
cell line that can help us study the long-term effects of inflammatory signaling. As the NF-κB pathway 
lies at the intersection of many stress response pathways, this synthetic memory circuit will be useful for 
studying a variety of disease pathologies. 
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Materials and Methods  
Plasmid constructs 
Escherichia coli DH5α was used for all plasmid manipulations. Bacteria were grown in LB-ampicillin 
media to maintain plasmids; if engineered constructs contained synthetic zinc fingers, media was 
supplemented with 0.02 mM zinc chloride. DNA fragments were generated by PCR and assembled via 
restriction cloning or Gibson assembly (Gibson et al. 2009). 
 Response elements from human p53R2 gene (Ohno et al. 2008), IL-1β gene (Hiscott et al. 
1993), or pNiFty3 vector (Invitrogen) were constructed as annealed oligos (Integrated DNA 
Technologies) and ligated in front a minimal promoter (Shibata, Giaccia, and Brown 2000) to generate 
the p53R2-RE and NRE1-4 promoters. Human codon-optimized synthetic zinc fingers (Hurt et al. 
2003) were commercially synthesized by Mr. Gene (Regensburg, Germany).  
 For transient transfections, memory devices or triggers were cloned into a pcDNA3.1™ (+)-
based vector (Invitrogen) in which the neomycin resistance marker was replaced with puromycin 
resistance, and the constitutive CMV promoter was deleted (Silver Lab). 
 
Cell culture  
MCF7, T47D cells were grown in DMEM media supplemented with 10% fetal bovine serum (FBS) and 
1% penicillin and streptomycin. MCF10A cells were grown in DMEM supplemented with 5% horse 
serum, 20 ng/uL EGF (Peprotech), 0.5 mg/mL hydrocortisone (Sigma), 100 ng/uL cholera toxin 
(Sigma), 10 ug/mL insulin (Sigma) and 1% penicillin and streptomycin. U2OS cells were grown in 
McCoy’s 5A medium supplemented with 10% tetracycline-screened FBS and 1% penicillin and 
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streptomycin; βTC-6 cells were grown in DMEM supplemented with 10% FBS and 1% penicillin and 
streptomycin. All cell lines were grown at 37˚C in a humidified CO2 incubator.  
  
Transfection of U2OS and βTC-6 cells 
Transient transfections were performed by plating 1.2 X 105 cells/well in 12-well culture dishes and 
transfecting with 800 ng plasmid DNA and 2 ul Lipofectamine® 2000 (Invitrogen) in 1 ml of antibiotic-
free medium. Cells were exposed the following day to γ or UV radiation, LPC treatment 
(lipopolysaccharide, 20 μg/mL; PMA, 10 ng/mL; db cAMP, 100 μM) or IL-1β (0.1 ug/mL) (Cogswell 
et al. 1994) and analyzed by flow cytometry. 
  
Induction of DNA damage, hypoxic and inflammatory response 
To induce the DNA damage response in MD12/p53R2-RE cells, 3.0 x 105 cells/well were plated in 6-
well plates. The following day, plates were exposed to a brief burst of 10 J/m2  shortwave ultraviolet 
radiation (UV) (Lahav Lab, Harvard Systems Biology) or varying levels of γ-radiation from a Ce source 
(Harvard Medical School). To induce hypoxia, 3.0 x 106 cells were plated in 10 cm plates. The following 
day, plates were exposed to hypoxia (0.5% O2, 5.0% CO2) in a hypoxic chamber (Kaelin lab, Dana 
Farber Cancer Institute). When cells were returned to normoxia, media was replaced with appropriate 
maintenance media. To induce inflammation and NF-κB signaling, cells were exposed to LPC treatment 
(lipopolysaccharide, 20 μg/mL; PMA, 10 ng/mL; db cAMP, 100 μM) or 0.1 ug/mL IL-1β (Cogswell et 
al. 1994) for 24 hours.  
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Fluorescence microscopy 
Cells were imaged at 20x with a Nikon TE2000-E inverted fluorescence microscope equipped with a 
Hamamatsu ORCA-ER camera, and HcRed (RFP) and JP2 (YFP) filters (Silver Lab). Images were 
acquired and analyzed using Metamorph software.    
 
Flow cytometry and cell sorting 
Cells were trypsinized and resuspended in PBS before being loaded in 96 well plates or 5 mL polystyrene 
tubes (BD Biosciences) on an LSRII (BD Biosciences) with 488-nm (DsRed) and 568-nm (Fitc) lasers 
(Harvard Systems Biology). 1.0 X 104 cells were analyzed for RFP (DsRed) and YFP (FITC) 
fluorescence and gated based on cell size and granularity. Unexposed cells controlled for basal 
fluorophore expression. Data was analyzed using FlowJo software. 
 To sort MD12/p53R2-RE cells, 12, 6-well plates were exposed to γ-radiation and recovered for 
3 or 5 d. Cells were then processed as described above, except that 4, 6-well plates of cells were pooled to 
produce three replicates.  
Processed cells were run on a FACS Aria II with a 100 uM nozzle at 20 psi (Harvard Systems 
Biology). Excitation optics for RFP consisted of a 75 mW 594 nm laser; detection optics included a 
630/22 bandpass filter. Excitation optics for YFP consisted of a 15 mW 488 nm laser; detection optics 
included a 520 nm longpass dichroic mirror and a 530/30 bandpass filter. For microscopy, 200,000 
memory and non-memory cells were sorted. Sorted MD12/p53R2-RE cells were seeded in 24-well 
dishes. 
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Endogenous pathway induction for RT-PCR 
MD12/p53R2-RE and U2OS cells were plated and exposed to γ-radiation or hypoxia, respectively. 
Whole cell RNA was extracted using the RNeasy Mini Kit (Qiagen), and cDNA was prepared using the 
SuperScript III First Strand Synthesis System (Invitrogen). Unexposed cells served as controls for 
background expression. 
Differential expression of genes was analyzed by real-time PCR using 0.5 ug RNA of specified 
cell populations. Primers amplified ~ 100 base pairs (Table B.1). Differential expression was normalized 
to human gene ACTB or GAPDH. 
 
Gene expression profiling 
U2OS cells were plated in 10 cm plates, exposed to 0.5% O2 for 24 h in triplicate, and allowed to recover 
for 3, 5, 7, and 9 d. Unexposed cells were plated the same way and passaged at the same time. For each 
biological replicate, RNA was extracted from exposed and unexposed cells using the RNeasy Mini Kit 
(Qiagen). For the 0 and 3 d time points, cDNA was prepared, biotinylated, and hybridized to Gene 1.0 
ST arrays (Affymetrix). Arrays were scanned and quantified according to standard Affymetrix protocols 
at the Dana Farber Microarray Core Facility (Dana Farber Cancer Institute).  
 
Identification and analysis of differentially regulated genes 
Data was annotated and normalized by RMA-analysis using Affymetrix Expression Console Software.  
Differential gene expression was determined using the Matlab Bioinformatics Toolbox (MathWorks). P-
values were calculated using a permutation t-test of 10,000 permutations. Genes with a fold change ≥ 2 
and p-value ≤ 0.05 were considered differentially expressed and analyzed for gene ontology enrichment 
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via GoStat (http://gostat.wehi.edu.au), with Benjamini correction for multiple hypothesis testing; 
enrichment was considered significant with P ≤ 0.01. 
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Building a Pulse-Detecting Genetic Circuit  
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Abstract  
The design and engineering of a robust event counter has been a goal in the synthetic biology field for 
many years. While preliminary counting circuits capable of detecting a few events have been built, 
designing a reliable and scalable counter is still a difficult task. One difficulty facing event counter 
function is the ability to define a single event, or pulse, regardless of its duration. To accomplish this, we 
propose a novel design for a pulse-detecting genetic circuit that responds specifically to the falling edge 
of a pulse. In this Chapter we discuss the characterization of a dominant negative mutant of cI protein as 
a potential component of a pulse detecting genetic circuit and describe preliminary characterization of 
the lambda switch as a functional pulse detector.  
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Introduction 
In previous Chapters, we discussed the development and applications of synthetic cellular memory 
devices. We showed that these devices can be used to study heterogeneous responses to cellular stresses 
and discussed their future applications in drug development and tissue engineering. However, memory 
devices are also a key component of a more complex circuit: a counter(Subsoontorn and Endy 2012). 
An isolated memory device can be thought of as a 1-counter as it toggles between 2 states. By linking 
multiple orthogonal memory devices together, we can build counters that can count higher. While 
unidirectional memory devices like the ones discussed earlier in this dissertation can be used to build a 
counter, the limit of counting is equal to the number of switches(Subsoontorn and Endy 2012). This 
makes counting to high numbers challenging, as many orthogonal systems must be designed. 
Alternatively, reversible or bidirectional memory switches can also be used to build a counter. In this 
case, we can theoretically count much higher with fewer components.  
 Building a counter has been a goal in the field of synthetic biology for many years. Such a device 
would be very useful for studying disease progression in cancer, or learning more about development 
(Bonnet et al. 2013). A robust counter would also be useful in engineering cells – both eukaryotic and 
prokaryotic – to perform novel tasks. In complex electrical circuits and computation, counters play an 
integral role. If we hope to someday program biological systems with the same degree of sophistication, 
the development of well-characterized and functional counters will be essential. To date, significant 
progress has been made in building the necessary foundational memory switches. Unidirectional 
transcriptional memory switches based on both transcriptional positive feedback loops and DNA 
rearrangement have been studied extensively(Kramer et al. 2004; Ajo-Franklin et al. 2007; Burrill and 
Silver 2011; Burrill et al. 2012; Lou et al. 2012).  In addition, several groups have also developed 
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transcriptional double-negative feedback loops – toggle switches – and reversible DNA rearrangement 
based switches creating bidirectional memory(Gardner, Cantor, and Collins 2000; Ham et al. 2008; 
Bonnet, Subsoontorn, and Endy 2012; Siuti, Yazbek, and Lu 2013). However, only a few circuits with 
limited counting ability have been created(Friedland et al. 2009).  
 One obstacle standing in the way of building a robust event counter is the ability to detect a 
single event regardless of the length of its occurrence. For example, previous counters were sensitive to 
the length of time they are exposed to inducer; too short and the count is not advanced, too long and the 
count moves ahead too far(Friedland et al. 2009). This decreases the modularity of the device, as it can 
be tuned to work in a certain situation but may fail if moved to a different context. We propose to build a 
pulse detector that responds only to the falling edge of a pulse of stimulus. This would mean, regardless 
of the length of exposure to inducer, a counter would only advance at the end of the pulse (Figure 4.1). 
While synthetic circuits have been built that respond to the rising edge of a stimulus by generating a 
pulse of output(Basu et al. 2004), our design represents the first synthetic biological circuit that detects 
the end of a pulse of stimulus. 
 
Figure 4.1. A pulse detecting genetic circuit responds to the falling edge of a pulse of stimulus. Our 
proposed design for a pulse-detecting genetic circuit will have no output when inducer levels are low or 
high, however, when transitioning from high to low inducer, the circuit should produce a pulse of 
output. 
time
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Our design for the pulse detector is based on the lambda cI repressor protein(Ptashne et al. 
1980). This protein has several features that make this circuit possible. The lambda phage has both a 
lysogenic state – the phage is integrated in the E. coli genome and is replicated during cell division – and 
a lytic state – the phage produces many new phage particles and lyses the cell. This decision is made 
based on the stress on the bacterial host caused by environmental conditions. Controlling this behavior 
is a transcriptional switch consisting of the cI and cro genes transcribed from a divergent promoter (Prm 
and Pr, respectively)(Ptashne 2004) (Figure 4.2A). While cro represses expression of cI, cI represses cro 
expression as well as promoting its own expression(Hochschild, Irwin, and Ptashne 1983). However, 
high levels of cI expression will also shut down the Prm promoter maintaining cI at a moderate level. 
Thus, when cI is expressed, cro is repressed and the phage remains in a lysogenic state. However, if cro is 
expressed, cI is repressed and the phage enters the lytic cycle. Importantly for our design, cI normally 
binds to its operator sequences as a dimer(Ptashne 2004). A lambda phage unable to form lysogens was 
isolated and found to contain a mutation in the DNA binding domain of the cI protein (N55K)(Nelson 
and Sauer 1986). It was found that this mutation abolished binding specificity at the operator sequences 
and the non-specific DNA binding affinity was increased, however it should not interfere with 
dimerization of the protein. We refer to this protein as dominant-negative cI (cIDN). 
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Figure 4.2. Components of the lambda phage switch can be used to build a pulse detecting genetic 
circuit. 
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Figure 4.2 (continued). Components of the lambda phage switch can be used to build a pulse detecting 
genetic circuit. (A) The lambda switch is a bistable switch consisting of a double negative feedback loop 
where cI and cro repress the other’s transcription. In addition, cI also activates its own expression from 
the Prm promoter. (B) A pulse detecting genetic circuit can be designed by coexpressing a dominant-
negative mutant of cI along with wild-type cI, and building a cI reporter using the Prm promoter. By 
increasing the degradation rate of cIDN, a pulse detector is created. (C) When no inducer is present, 
neither cIDN nor cI is expressed and there is no output. When inducer is added, both proteins are 
expressed, cIDN blocks cI function, and no output is detected. However, when inducer is removed, cIDN 
degrades and cI can activate expression of the reporter gene. 
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We propose building a pulse detecting genetic circuit by co-expressing a degradation tagged cIDN 
and wild-type cI from a single inducible promoter (Figure 4.2B). A reporter gene will be expressed from 
the Prm promoter. Before induction, neither cIDN or cI will be produced and no output is expected from 
the reporter gene. When the circuit is induced, both cIDN and cI will be produced, cIDN will block cI 
function and still no reporter expression will be observed. Only when inducer is removed will cIDN 
degrade leaving cI to dimerize and activate reporter expression (Figure 4.2C). This will produce a novel 
pulse-detecting circuit that reports on the falling edge of a stimulus. 
 
Results and discussion 
Construction of inducible cI and cIDN genes 
To engineer a pulse detecting circuit, we first built a small library of inducible cIDN variants and an 
inducible wild-type cI. To characterize the interaction between cIDN variants and cI protein, we used a 
reporter plasmid obtained from the Registry of Biological Parts. This plasmid contains a modified Prm 
promoter driving transcription of a degradation-tagged sfGFP gene(Huang, Holtz, and Maharbiz 2012). 
The promoter has been modified to eliminate auto-inhibition by high levels of cI so that expression of 
the reporter will increase with higher levels of cI expression, even if these are beyond the natural level of 
cI repressor maintenance(Huang, Holtz, and Maharbiz 2012). 
 In the initial design of the characterization strains, we planned to express cI repressor from the 
arabinose-inducible pBAD promoter(Guzman et al. 1995). Using gene synthesis, we built a plasmid 
containing araC and the pBAD promoter followed by the wild-type cI gene. This construct was 
integrated in the phi80 phage attachment site using the CRIM integration system. This strain was then 
transformed with the Prm sfGFP reporter plasmid (Figure 4.3A, Table 4.1). Cells containing inducible  
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Figure 4.3. A fluorescent reporter system for lambda cI activity. 
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Figure 4.3 (continued). A fluorescent reporter system for lambda cI activity. (A) A fluorescent reporter 
of cI activity was built by integrating an arabinose-inducible cI gene into the genome of E. coli. These 
cells were then transformed with a reporter plasmid carrying sfGFP transcribed from a modified PRM 
promoter (PRM-GFP)(Huang, Holtz, and Maharbiz 2012). This promoter has mutations in OR3 
preventing auto-inhibition by high levels of cI. (B) Cells carrying the PRM-GFP (MCI001) were 
exposed to 10mM arabinose for 4 h and then imaged by microscopy. Induced cells showed a much 
higher GFP signal. (C) The induced and uninduced cells were also analyzed by flow cytometry. Induced 
cells had a significantly higher GFP signal, however, uninduced cells also showed GFP expression. (D) 
The reporter system was rebuilt by replacing pBAD cI with a rhamnose-inducible cI gene while the 
reporter plasmid remained unchanged (MCI002). (E) MCI002 cells were induced with varying 
concentrations of rhamnose for 4 h and analyzed by flow cytometry. The percentage of GFP positive 
cells increased in a dose dependent manner. 
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cI and reporter (MCI001) were then grown in the presence and absence of 10 mM arabinose in LB and 
then analyzed by flow cytometry and microscopy (Figure 4.3B,C). As expected, we observed a 
significant increase in GFP expression upon induction of cI. However, we also observed expression of 
GFP, albeit at a much lower lever, in the absence of arabinose. This was most likely due to incomplete 
repression of the pBAD promoter. Indeed, we observed a significant growth defect in the pBAD cI strain 
compared to the parent strain even in the absence of reporter plasmid. This suggests that expression of 
the cI protein is toxic to the cells. The growth difference was suppressed by addition of glucose to the 
growth media causing tighter repression of the arabinose genes. In addition, we ordered constitutively 
expressed versions of the cI repressor and not only was production of these constructs seriously delayed, 
propagation of the resulting plasmids was difficult further supporting the hypothesis that expression of 
the repressor was toxic. 
As the arabinose promoter showed significant leaky expression, we decided to rebuild the 
inducible cI construct with the rhamnose-inducible pRham promoter(Giacalone et al. 2006). The 
rhamnose-inducible cI construct was integrated at the araB locus by recombineering. This strain was 
then transformed with PRM-GFP (Figure 4.3D). Cells containing the rhamnose-inducible cI and the 
reporter plasmid (MCI002) were then induced with several concentrations of rhamnose and analyzed 
by flow cytometry (Figure 4.3E). We observed increasing expression of GFP with increasing amounts of 
rhamnose showing that our reporter system was functioning correctly. 
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Table 4.1. List of strains used in this study. 
Strain 
name 
Host Genotype Plasmid Source 
MCI001 BW25113 attPφ80::gentR-pBAD->cI ind- 
PRM-
GFP this study 
MCI002 BW25113 araB::CAMR-pRham->cI ind- 
PRM-
GFP this study 
MCI003 BW25113 
araB::CAMR-pRham->cI ind-, 
putAP::CAMR-tetP-> cIDN 1 
PRM-
GFP this study 
MCI004 BW25113 
araB::CAMR-pRham->cI ind-, 
putAP::CAMR-tetP->cIDN3 
PRM-
GFP this study 
MCI005 BW25113 
araB::CAMR-pRham->cI ind-, 
putAP::CAMR-tetP->cIDN4 
PRM-
GFP this study 
PAS132 MG1655 
araB::CAMR-tetP->cro, mphR:KanR-OL-
rexBA-cIind--OR-cro::lacZ, rpsLK42R none 
(Kotula et al. 
2014) 
MCI006 MG1655 
putAP::CAMR-tetP->cIDN2, mphR:KanR-
OL-rexBA-cIind--OR-cro::lacZ, rpsLK42R none this study 
TB10 MG1655  none 
(Thomason et al. 
2001) 
BW25113   none 
(Haldimann and 
Wanner 2001) 
 
 We also synthesized several tetracycline inducible cIDN variants: a single mutant (N55K), and a 
triple mutant (N55K, Y88E, T154E) both with and without degradation tags. While the N55K mutation 
is reported to interfere with specificity of DNA binding, the Y88E and T154E mutations are novel. We 
expect that the N55K mutation will affect DNA binding but not dimerization. If a cIDN monomer will 
bind to other cIDN monomers with the same affinity as wild-type cI monomers, a pool of non-productive 
cIDN homodimers will form. We selected the Y88E and T154E mutations – these mutations lie at the 
protein-protein interface in the crystal structure of the cI dimer(Stayrook et al. 2008) – in an effort to 
discourage homodimerization without affecting heterodimerization, thus, lowering the concentration of 
cIDN monomer necessary to block cI function (Figure 4.4). Conversely, if these mutations also interfere  
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Figure 4.4. Structural model of lambda cI and cIDN heterodimer bound to DNA. In this model of cI 
dimer bound to DNA(Stayrook et al. 2008), we colored the residues mutated in the cIDN in red, N55K 
(at the DNA binding interface), Y88E (center) and T154E (top) at the interface between the two 
monomers. 
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with dimerization, we would observe a weaker effect on cI function. After synthesis of the single and 
triple mutants, we proceeded to make all other single and double mutants by site-directed mutagenesis. 
 
Table 4.2. List of cIDN mutants: 
cIDN mutant Mutations Degradation tag 
cIDN 1 N55K N 
cIDN 2 N55K Y 
cIDN 3 N55K, Y88E, T154E N 
cIDN 4 N55K, Y88E, T154E Y 
cIDN 5 N55K, Y88E N 
cIDN 6 N55K, Y88E Y 
cIDN 7 N55K, T154E N 
cIDN 8 N55K, T154E Y 
cIDN 9 Y88E, T154E N 
cIDN 10 Y88E, T154E Y 
cIDN 11 Y88E N 
cIDN 12 Y88E Y 
cIDN 13 T154E N 
cIDN 14 T154E Y 
 
Characterization of interaction of cI and cIDN	   
After building a small library of cIDN constructs we began to characterize their ability to interfere with cI 
function. After integrating the tet-inducible cIDN 1-4 constructs, these were transduced into the 
rhamnose-inducible cI strain. Resulting strains were transformed with the PRM-GFP(Huang, Holtz, and 
Maharbiz 2012) (Figure 4.5A). Colonies were grown overnight, back diluted 100-fold and induced with 
varying concentrations of rhamnose (0, 0.1, 1, and 10 mM) and ATC (0, 1, 10, and 100 ng/mL) for 5 
hours. Cells were then pelleted, resuspended in PBS, and analyzed by flow cytometry (Figure 4.5B-G). 
In all cases, increased expression of GFP was observed with increasing amounts of rhamnose. In 
addition, addition of 100 ng/mL ATC significantly decreased GFP expression at most levels of ATC  
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Figure 4.5. cIDN inhibits cI activity in a dose dependent manner. 
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Figure 4.5 (continued). cIDN inhibits cI activity in a dose dependent manner. (A) Strains were built 
containing rhamnose-inducible cI, one of several tet-inducible cIDN variants, and reporter plasmid. The 
single N55K mutant (B,C), triple N55K, Y88E, T154E mutant (D,E), and degradation-tagged triple 
mutant (F,G) were assayed for their ability to block cI function. Cells were induced with varying 
concentrations of rhamnose in the absence or presence of 100 ng/uL aTC (B, D, F) and varying 
concentrations of aTC in the presence or absence of 1 mM rhamnose (C, E, G) and then analyzed by 
flow cytometry. Two biological replicates were measured for each strain in each condition, and 100,000 
cells were measured. 
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induction. The effect was much stronger in the case of the single mutant (Figure 4.5B), completely 
eliminating gfp expression at all levels of rhamnose. This repression occurred in a dose dependent 
manner(Figure 4.5C). Cells were induced with 1 mM rhamnose and increasing concentrations of ATC. 
As the level of induction of cIDN increased, more repression of gfp was seen. This demonstrates that the 
cIDN mutants are interfering with wild-type cI function as expected. These results also show that the 
triple mutant is less effective than the single mutant. This may be due to decreased dimerization, poor 
protein folding, or decreased stability of the protein. In addition, we observe a weaker effect of the 
degradation-tagged triple mutant compared to the plain triple mutant. This is expected as the increased 
degradation rate will result in a lower concentration of cIDN at a given induction level. While we do not 
currently have the corresponding data for the single mutant, we infer that a similar effect would be 
observed. 
 
Design of pulse-detecting genetic circuit 
In the process of designing the pulse-detecting circuit, we modeled the expected behavior of the circuit 
using ordinary differential equations (ODEs). Rather than model the induction of the circuit we set the 
initial parameters for the amount of cI and cIDN protein explicitly. This represents what would happen 
after a period of constant induction long enough for cI and cIDN concentration to reach steady-state 
levels. We expect to see no expression of reporter at time 0 in the simulation and over time, a pulse of 
reporter should appear as cIDN degrades. Indeed, with certain sets of parameters (Tables C.1-C.3) for 
relative initial concentrations and degradation rates of the two proteins, this behavior is observed. 
Importantly, while the modeling does not predict specific values, it suggests that we should choose 
ribosome binding sequences so that cIDN concentration is at least 10 fold higher than cI concentration at  
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steady state. In addition, the degradation of cIDN must be significantly faster than cI to produce a pulse of 
output.  
 
State of assembly of pulse detector library 
In an effort to build genetic constructs that fulfill the requirements revealed by modeling, we decided to 
construct a moderately sized library of candidate designs. We chose a standard ssrA degradation tag for 
cIDN that has been fairly well characterized and shown to be quite strong (Huang, Holtz, and Maharbiz 
2012). We placed the cI gene after the cIDN gene in a single operon(Figure 4.1B). This will ensure both 
proteins are expressed together and the placement of cIDN first in the operon should result in higher 
expression levels separate from RBS strength. We then designed 24 variants of the RBS for both the cIDN 
and cI genes to try and tune expression of the two proteins. This library was being built in collaboration 
with Ginkgo Bioworks by leveraging their automated assembly pipeline. However, the toxicity of 
spurious cI and cIDN expression made automated assembly of the library problematic and we were not 
able to assemble an acceptable library of constructs. We are proceeding with building a smaller library 
manually.  
 
Lambda memory switch as a pulse detector 
While the original design for a pulse detecting genetic circuit involved controlling the activity of cI 
repressor through interaction with a dominant negative mutant, there are other ways of achieving this 
goal. In our lab, we have taken advantage of the lambda switch to build a robust memory device in E. 
coli(Kotula et al. 2014). The lambda switch was integrated into the genome so that Pr cro read directly 
into lacZ. In the initial cI state, cells would not express lacZ (Figure 4.6A), however, when cro was  
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Figure 4.6. The natural lambda switch can function as a pulse detector.  
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Figure 4.6 (continued). The natural lambda switch can function as a pulse detector. (A) In the basal 
state of the lambda based memory device (PAS132), cI is expressed repressing cro and lacZ expression. 
(B) When cro expression is induced from an exogenous tet-inducible promoter, cro is produced to a 
high enough level to repress expression of cro and lacZ from the Pr promoter. (C) Conversely, when 
cIDN is expressed from an exogenous tet-inducible promoter (MCI006), it interferes with cI but does not 
affect the Pr promoter. This allows cro and lacZ to be expressed from the Pr promoter, switching the 
device to the cro state immediately. (D,E) Cells were induced with 100 ng/mL aTC, aliquots were 
diluted in PBS and plated on LB plates containing kanamycin without aTC (D) or containing 100 
ng/mL aTC (E). On plates without aTC, both the cro trigger and cIDN trigger were able to switch 
100% of the population after 4 h. However, when plated on reporter plates containing aTC, cells 
expressing cIDN are 100% switched, while cells expressing cro remain unswitched. 
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expressed exogenously from a tetracycline-inducible promoter, cells would switch to the cro state and 
express lacZ (Figure 4.6B). This switching can be detected by growing cells on plates containing X-gal 
and looking for blue colonies. They showed that this circuit also specifically reports on aTC exposure 
when cells are introduced in the gut of a mouse, demonstrating its potential use as a diagnostic probiotic. 
During the characterization of this device, it was noted that no switching was observed during 
induction. LacZ expression was only detected once cells were plated on reporter plates. As mentioned 
earlier, while cI promotes its own expression from the Prm promoter, it also inhibits its production once 
levels are too high. Similarly, cro can also inhibit its own expression from the Pr promoter if it is present 
in high enough amounts; for instance, when expressed from a tetracycline-inducible promoter. This is 
demonstrated by comparing the switching of the device by expression of cro and expression of cIDN. We 
integrated the tet-inducible cIDN into PAS132 where pTet cro had been deleted(MCI006). We expect 
that when cIDN is expressed, it will interfere with cI binding leaving the Pr promoter free allowing 
expression of cro and lacZ (Figure 4.7C). When induced with aTC, both cro and cIDN induce switching 
of the device (Figure 4.6D). However, when plated on reporter plates containing aTC, cells expressing 
cIDN are 100% switched, while cells expressing cro remain white (Figure 4.7E). Thus, the lambda 
memory switch already functions as a pulse-detecting circuit.  
 
Conclusions 
While the construction of the complete pulse-detecting circuit is still ongoing, in this Chapter we have 
described the characterization of a dominant-negative mutant of cI. This will allow future assembly of 
more complex circuits. In addition, we demonstrated that an existing device – the lambda memory 
	   109 
switch – already behaves as a pulse detector. These types of devices will allow better control over gene 
expression in engineered cells in the future.  
 
Materials and Methods  
Plasmid construction  
Escherichia coli NEB Turbo Competent (NEB), BW23474, and BW23473 were used for all plasmid 
manipulations. Bacteria were grown in LB media with either 10ug/mL chloramphenicol, 20ug/mL 
kanamycin, 10ug/mL gentamycin, or 100ug/mL ampicillin to maintain plasmids as appropriate. DNA 
fragments with were generated by PCR and assembled via Gibson assembly(Gibson et al. 2009). 
Inducible cI and cIDN constructs were cloned into CRIM plasmids containing the R6Kgamma origin of 
replication(Haldimann and Wanner 2001) and one of several phage attachment sites. These  plasmids 
can only be propagated in pir+ hosts such as BW23474 and BW23473. 
 
Bacterial strain construction 
Constructs built in CRIM plasmids were integrated as described(Haldimann and Wanner 2001). In 
brief, the recipient E. coli were transformed with a helper plasmid expressing the appropriate integrase, 
made electrocompetent, and transformed with plasmid containing the construct to be integrated. Cells 
were then selected on appropriate antibiotic and screened for loss of helper plasmid. Integration was 
verified by colony PCR and Sanger sequencing. 
 Later, constructs were built by overlap extension PCR(R Higuchi 1988) and integrated directly 
into the genome by recombineering(Thomason et al. 2001). Recipient cells were transformed with 
pKD46, made electrocompetent, and transformed with PCR product. Alternatively, PCR product was 
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electroporated into TB10 that do not require a helper plasmid. In both cases, cells were then recovered 
at 30 degrees for 1 h and heat shocked at 42 degrees for 30 min. Cells were then plated on LB plates 
containing appropriate antibiotics and grown at 37 degrees. Integration was confirmed by colony PCR 
and Sanger sequencing. Strains containing multiple constructs were made by moving previously 
integrated constructs into the final strain using P1 transduction. 
 
Flow cytometry 
Cells containing PRM-GFP plasmid (Addgene plasmid 40127) were back diluted 1:100 in LB with 
ampicillin, induced with various concentrations of rhamnose (0, 0.1, 1, 10 mM) and ATC (0, 1, 10, 100 
ug/mL) for 5 h. Induced cultures were spun down, resuspended in 1x PBS, and diluted 50 fold in PBS. 
Cells were later loaded in 96 well plates (BD Biosciences) on an LSRII (BD Biosciences) with a 568-nm 
(FITC) laser (Harvard Systems Biology). 1.0 X 105 cells were analyzed for GFP (FITC) fluorescence 
and gated based on cell size and granularity. Unexposed cells controlled for basal fluorophore 
expression. Data was analyzed using FlowJo software. 
 
Microscopy 
Cells were imaged at 100x with a Nikon TE2000-E inverted fluorescence microscope equipped with a 
Hamamatsu ORCA-ER camera, and HcRed (RFP) and JP2 (YFP) filters (Silver Lab). Images were 
acquired and analyzed using Metamorph software.  
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Lambda memory switching assay 
Strains were grown overnight in LB supplemented with 20 ug/mL kanamycin. Cultures were 
backdiluted in fresh LB with antibiotics and induced with 100ng/mL aTC. Aliquots of culture were 
diluted by serial dilution between 10-3 to 10-6 in PBS then 100 uL were plated on LB plates containing 
kanamycin and 20 ug/mL X-Gal. Colonies were counted the following day and scored for lacZ 
expression. 
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Where are we now? 
 While synthetic biologists have been able to achieve ambitious goals, from engineering bacteria 
and mammalian cells to produce novel compounds(Wang et al. 2009), remember past events(Ajo-
Franklin et al. 2007; Burrill and Silver 2011; Bonnet, Subsoontorn, and Endy 2012; Burrill et al. 2012; 
Kotula et al. 2014), communicate with each other(Bulter et al. 2004), and compute complex 
logic(Lohmueller, Armel, and Silver 2012; Bonnet et al. 2013; Siuti, Yazbek, and T.K. Lu 2013); as far as 
rebuilding bacterial genomes(Benders et al. 2010; Gibson et al. 2010), and even an entire eukaryotic 
chromosome(Annaluru et al. 2014), the field has just begun to cross the threshold from building 
prototype circuits to creating useful tools. This is not meant to undermine what has already been 
accomplished. On the contrary, these projects are important and essential milestones on the path to 
learning to predictably and reliably engineer biological systems. Just as we learn more about the systems 
we try to build through our failures, we learn more about how to effectively design these systems through 
trial-and-error. For instance, we initially assumed we could abstract away much of the messiness of 
biology emphasizing its modularity(Purnick and Weiss 2009), but found this “noise” was actually 
important to build in to our designs(Daniel et al. 2013). This knowledge, alongside the development of 
high-throughput screening and selection techniques, led to the strategy of casting a wide net by building 
and testing every conceivable variant of a circuit. However, it is becoming apparent that a more 
restrained approach falling somewhere between these two extremes is often the most efficient 
tactic(Silver et al. 2014).  
 In this dissertation, we discussed the development of synthetic memory circuits and a pulse 
detecting circuit. In Chapter 2, we showed that by treating promoters, and protein coding regions as 
modular units, you could build transcriptional memory circuits triggered by a variety of inputs. While 
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the building and testing of the initial prototype circuit was difficult and time-consuming, the modularity 
of this system with respect to the trigger promoter made it a relatively simple matter to modify this 
device to respond to novel inputs. By changing one element, we were able to change the input from 
doxycycline exposure, to either hypoxia, or DNA damage. Importantly, we showed that this circuit is 
useful in the study of long-term and heterogeneous responses to these stimuli. In Chapter 3, we explored 
further applications for this memory circuit, including the long-term effects of exposure to γ-radiation, 
and an effort to modify the promoter once again to respond to inflammation. Chapter 4 describes the 
effort to rationally design a pulse-detecting circuit. By combining, abstraction with modeling of the 
relevant protein interactions, we showed that it would be possible to design a small library of candidate 
designs that can be screened for proper function. While the projects in Chapters 2 and 3 rely on our 
ability to abstract biology into elements such as promoter and transcription factor, Chapter 4 falls more 
closely into the new paradigm of combining this abstraction with rational design of a limited library of 
constructs.  
 
What stands in our way? 
 Even though we understand a lot about transcriptional networks and cellular signaling, creating 
novel circuits that function as intended both in vitro and in vivo remains a difficult challenge. In addition, 
circuits that function reliably in one context can become unpredictable when moved to a different 
environment, often through changes as subtle as modified growth medium. While natural biological 
circuits have had the opportunity to evolve robustness to these types of changes, our novel circuits have 
not had that chance. In an effort to streamline and simplify synthetic genetic networks, we may even be 
designing out the flexibility needed to build a robust device. Currently, the design of the architecture of 
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synthetic circuits is mostly done by intuition, or mimicry of natural circuits. It is not unreasonable to 
assume this is limiting the variety of circuits being developed. To address this issue, as well as to speed up 
the design process in general, significant effort is being put into the development of computer aided 
design (CAD) programs(Chandran, Bergmann, and Sauro 2009; Cai, Wilson, and Peccoud 2010; 
Clancy and Voigt 2010). This would automate the “coding” portion of the design process enabling 
researchers to define inputs and desired outputs while the software would design the actual genetic 
network allowing us to test non-intuitive designs. 
 In addition to the design process, the actual building and delivery of our designed circuits also 
remains challenging. While techniques for efficiently assembling several small pieces (several kb to 
hundreds of kb) of DNA have become commonplace in many academic labs(Gibson et al. 2009), as 
designs become more complex, assembly of large numbers of constructs (library preparation), and large-
scale constructs (> 1 Mb) are still beyond the reach of most researchers. However, as with earlier 
assembly techniques, recent breakthroughs in the construction of whole genomes(Benders et al. 2010) 
and chromosomes(Annaluru et al. 2014) will open the door for others. In addition, the falling cost of 
synthesis and creation of synthetic biology companies focused on bulk production of constructs will 
enable researchers to test large numbers of designs more quickly. As libraries and individual constructs 
become larger, efficient delivery to the cell becomes more challenging as well. In the end, the current 
roadblocks and obstacles in the design and building of novel synthetic circuits are mostly technical in 
nature, so we can anticipate they will eventually be solved. Hopefully, in the near future, testing of 
candidate designs will be the rate-limiting step for synthetic biologists. The most important question we 
need to ask is not how, but what do we want to design and why? 
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Where do we go from here? 
 In this dissertation, we have demonstrated that synthetic biology has the potential to help us 
answer questions that would be difficult to investigate by traditional means. For instance, we used 
synthetic memory circuits to learn more about long-term and heterogeneous responses to transient 
stimuli. Building synthetic circuits also lets us learn more about the natural circuits that inspire them. 
However, the potential of synthetic biology is greater than just as a tool for learning about biology. For 
example, we could develop engineered cellular therapies that would be programmable “smart” 
therapeutics. These could be nanostructures or other vectors for delivering drugs to specific tissues or 
cell types, or even engineered cells, such as T-cells, delivered directly into the blood stream(Ruder, T. 
Lu, and Collins 2011; Ausländer and Fussenegger 2012). Synthetic biology approaches could eventually 
be used to program stem cell differentiation to engineer tissues. Bacteria can be modified to become 
engineered probiotics that can diagnose or potentially treat disease. It is easy to be optimistic about the 
future of synthetic biology. Its potential seems bounded only by our imagination. However, this 
optimism must be tempered with the knowledge that we still have technical hurdles and obstacles to 
overcome.  
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Supplementary figures1 
                     
(A)    (B)    (C) 
 
 
 
 
 
 
 
 
Figure A.1. Transient transfections. (A) Reporters and loops were transfected to detect basal activity. 
(B) Reporters and loops were mismatched and transfected to determine orthogonality. (C) p53R2-RE 
and HRE triggers and loops were co-transfected.         
 
 
 
 
 
 
 
 
 
 
Figure A.2. Representative FACS scatter plots demonstrating how MD10/TetOx2 was analyzed by 
flow cytometry. “+dox”: 24 h dox exposure. “2 d post-dox”: 48 h recovery from dox exposure.      
           
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Portions of this chapter were reproduced with permission Cold Spring Harbor Laboratory Press: 
Burrill DR, Inniss MC, Boyle PM, Silver PA. 2012. Synthetic memory circuits for tracking human cell fate. Genes Dev 
26:1486–1497.	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Figure A.3. Selected MD10/ TetOx2 clones behaved similarly. Each row of FACS plots represents a 
clone. 
 
 
 
 
Figures A.4. RFP (left) and YFP (right)   degrade at similar rates. MD10/TetOx2 was exposed to dox to 
induce fluorophore expression and then exposed to cycloheximide (CHX) to observe protein decay. 
Aliquots were fixed each hour and fluorescence was measured by FACS.     Decay was measured as a 
percentage of starting intensities at time 0 h of CHX exposure. 
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 (A)       (B)           (C) 
 
 
 
Figure A.5. FACS scatter plots (top row) showing distribution of fluorescence intensity when 
MD15/HRE and MD12/p53R2-RE are activated by (A) anoxia, (B) hypoxia, or (C) UV. Fluorescence 
intensities in each quadrant are shown below each scatter plot. Error bars represent the mean ± SE for 
three biological replicates. 
 
 
 
 
Figure A.6. FACS scatter plots showing distribution of fluorescence intensities when MD15/HRE and 
MD12/p53R2-RE are activated by anoxia, hypoxia, or UV and recovered for 2 d. 
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(A)  (B) 
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Figure A.7. Growth and viability of stable cell lines. (A) MD15/HRE memory cells were sorted 1 d 
post-hypoxia and growth was compared at subsequent time-points. (B) MD10/TetOx2 cells and (C) 
MD12/p53R2-RE were sorted 2 d post-UV or dox, and growth was compared at subsequent time-
points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.8. MD15/HRE transmits memory of hypoxia through cell division. Cells were exposed to 
hypoxia, sorted 1 d post-exposure for YFP+ cells, and followed by microscopy for 8 d. 
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Figure A.9. FACS scatter plots of MD12/p53R2-RE clones.  
 
 
 
(A) (B)
 
     
  
Figure A.10. qPCR validation of up-regulated genes in memory versus non-memory cells. (A) 
MD12/p53R2-RE and (B) MD10/TetOx2 cells were sorted 3 d post-UV or dox in biological triplicate, 
and RNA was extracted. Values represent mean fold difference in gene expression between memory and 
non-memory sub-populations ± SE across three biological replicates.  
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Supplementary Tables 
 
Table A.1. Transient transfection guidelines. 
construct amount (ng) construct amount (ng) 
trigger 400 reporter or loop 400 
Flp-In T-REx™ vector 400 reporter or loop 400 
trigger-spacer-reporter 800 ----- ----- 
trigger-spacer-loop 800 ----- ----- 
 
Table A.2. Media requirements for stable cell lines. 
integrated 
construct 
U2OS cell 
type 
antibiotic selection 
concentration 
(ug/mL) 
maintenance 
concentration 
(ug/mL) 
MD10/TetOx2 
 
Flp-In  
T-REx™ 
hygromycin 
puromycin 
blasticidin 
300 
3 
15 
100 
1 
15 
MD12/p53R2-RE plain puromycin 3 1 
MD15/HRE plain puromycin 3 1 
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Table A.3. Primer sequences used for real-time PCR. 
 
 Gene  Sequences (5’- 3’, forward first, reverse second) 
 ACTB  tccctggagaagagctacga, aggaaggaaggctggaagag 
 OASL  tttctgcccatccttcagcgagc, ggacctggctttcacatactgctgg 
 TNFRSF9  ccgacctctctccgggagcat, tgcggagagtgtcctggctct 
 GBP4  ctcgaggatccaggcgcagg, ctggataacctggtgtgggcactg 
 CCL5  tacattgcccgcccactgcc, gggtgacaaagacgactgctggg 
 CXCL10  tggcacactagccccacgtt, tgctgagactggaggttcctctgc 
 RSAD2  accctgtccgctggaaagtgttc, gcaggacacttctttgtggcgct 
 CXCL11  tgctacagttgttcaaggcttcccc, cactgcttttaccccagggccta 
 CDNF  ttgcgccgggcttttggtct, ctttacatacttcacagtcggcccc 
 MXD1  gctccgactccgacagggaaat, atgctgccccgctcgtcaga 
 SLC39A2  agccagaggtcatcaccggcta, gctgatctgttctgcaccatgaact 
 GRK5  ggagggggctgcagaggtca, cgcgggggtctggaacgaag 
 DDIT3  atgttaaagatgagcgggtggcagc, ttgaacactctctcctcaggttcca 
 GPX3  tcgcagagccggggacaaga, tggtgagggctccgtactcg 
 CYP11A1  agcagggagcgacccggtat, acgttgccgagcttctcccttag 
 TOR1B  ccgctcaacgcttcggctct, gccagcccagccgtgtaagg 
 ABCB1  accagataaaagagaggtgcaacgg, tcccggcccggattgactga 
 CYP4F11  acaagtggagccgccaccg, acatgtccagtctggcgctgc 
 EGLN3  cgtggatcgggggcaacgag, gcaagccaccattgccttagacct 
 CYP4F12  actcgacccagatgtcggcca, ttgggtgcaatggcagctgagg 
 TP53INP1  agcccaagtagtcccagagtgga, tccactgggaagggcgaaagc 
 PDLIM1  tgaaccccaggaggtcctgcac, aggcgaggcggtaaagggca 
 DPP4  gagtgactccaccgcccgga, cacggtgtcttcatcgtcggc 
 P53R2  tccctcagcgcccgtagctt, atgatctctcatcctgatccagccc 
 P21  gcactcagaggaggcgccatgt, tcgctgtccactgggccgaa 
 APAF1  gcgagacagagccctgcacc, gctgtcaaccatgagccaagcct 
 DDB2  aggacgcgatggctcccaaga, ctaggaccggagcccttcgca 
 BAX  agcaaactggtgctcaaggccc, gtctcacccaaccaccctggtct 
 GADD45A  aagctgctcaacgtcgacccc, tctcgcagcaaaacgcctgga 
 MDM2  cgcgccccgtgaaggaaact, gcacatttgcctgctcctcacca 
 Maspin  ttctgcccagacacggtcgc, ccattgcgggcctggagtcac 
 P53  gccagactgccttccgggtc, gggacggcaagggggacaga 
 TP53INP1  agcccaagtagtcccagagtgga, tccactgggaagggcgaaagc 
 VEGF  aaggaggagggcagaatcat, cacacaggatggcttgaaga 
 CA-IX  tggaagaaatcgctgaggaaggct, agcactcagcatcactgtctggtt 
 GLUT1  atcgtggccatctttggctttgtg, ctggaagcacatgcccacaatgaa 
 EPO  cgggcatgggcactcccttg, agaggccagcccccatcctg 
 TF  gtgccagagtttccgcgacca, cgtttgccgcaatggccctga 
 TFR  acggaggacgcgctagtgttct, ttgccgagccaggctgaacc 
 NOS2  ggacccgcaccactacaggc, gtggcacggctggatgtcgg 
 ENO1  tgggtacccggagcacggag, tgaacttctagccactgggtctcgt 
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Supplementary Files 
File A.1. Time-lapse video of MD10/TetOx2. Cells were plated, exposed to dox for 1 d, and recovered 
for 1 d. Cells were then imaged every hour for 3 d. Phase, RFP, and YFP channels were overlaid using 
Metamorph software. Cells can be seen dividing and transmitting memory to daughter cells, as well as 
when the circuit does not remain active after division. 
 
File A.2. Transcriptional profiling array analysis of MD12/p53R2-RE and MD10/TetOx2. 
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Supplementary Tables 
 
Table B.1. qRT-PCR primer sequences 
 
Primer name Sequence 
p53 qPCR F CAGCACATGACGGAGGTTGT 
p53 qpCR R TCATCCAAATACTCCACACGC 
Atm qPCR F ATCTGCTGCCGTCAACTAGAA 
Atm qPCR R GATCTCGAATCAGGCGCTTAAA 
p21 qPCR F TGTCCGTCAGAACCCATGC 
p21 qPCR R AAAGTCGAAGTTCCATCGCTC 
Mdm2 qPCR F GAATCATCGGACTCAGGTACATC 
Mdm2 qPCR R TCTGTCTCACTAATTGCTCTCCT 
Rad51C qPCR F TTTGGTGAGTTTCCCGCTGTC 
Rad51C qPCR R AACTTCTTTGCTAAGCTCGGAG 
Ddb2 qPCR F ACCTCCGAGATTGTATTACGCC 
Ddb2 qPCR R TCACATCTTCTGCTAGGACCG 
Gadd45A qPCR F GAGAGCAGAAGACCGAAAGGA 
Gadd45A qPCR R CACAACACCACGTTATCGGG 
Bax qPCR F CCCGAGAGGTCTTTTTCCGAG 
Bax qPCR R CCAGCCCATGATGGTTCTGAT 
Fas qPCR F AGATTGTGTGATGAAGGACATGG 
Fas qPCR R TGTTGCTGGTGAGTGTGCATT 
RelB qPCR F CCATTGAGCGGAAGATTCAACT 
RelB qPCR R CTGCTGGTCCCGATATGAGG 
BclXL qPCR F GAGCTGGTGGTTGACTTTCTC 
BclXl qPCR R TCCATCTCCGATTCAGTCCCT 
C-Myc qPCR F TCCCTCCACTCGGAAGGAC 
C-Myc qPCR R CTGGTGCATTTTCGGTTGTTG 
Gapdh qPCR F ACAACTTTGGTATCGTGGAAGG 
Gapdh qPCR R GCCATCACGCCACAGTTTC 
 
 
Supplementary Files 
 
File B.1. Transcriptional profiling array analysis of MCF10A exposed to 0.5% O2 for 24 h and recovered 
for 3 d. 
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Supplementary Tables 
 
Table C.1. Model Equations 
 
d(pRM_D0)/dt = 1/cell*(-ReactionFlux6) 
d(lacZ_mRNA)/dt = 1/cell*(ReactionFlux9 + ReactionFlux10 + ReactionFlux11 - 
ReactionFlux14) 
d(lacZ_pro)/dt = 1/cell*(ReactionFlux12 - ReactionFlux13) 
d(cI_wt)/dt = 1/cell*( - -2*ReactionFlux1 - ReactionFlux2 - ReactionFlux4) 
d(cI_DN)/dt = 1/cell*(-ReactionFlux2 - -2*ReactionFlux3 - ReactionFlux5) 
d(pRM_D1)/dt = 1/cell*(ReactionFlux6 - ReactionFlux7) 
d(pRM_D2)/dt = 1/cell*(ReactionFlux7 - ReactionFlux8) 
d(cI_dimer)/dt = 1/cell*(ReactionFlux1 - ReactionFlux6 - ReactionFlux7 - ReactionFlux8) 
d(cI_mixed)/dt = 1/cell*(ReactionFlux2) 
d(cI_DN_dimer)/dt = 1/cell*(ReactionFlux3) 
 
 
Table C.2. Model Fluxes 
 
ReactionFlux1 = cI_dimerize.kdimF*cI_wt*cI_wt-cI_dimerize.kdimR*cI_dimer 
ReactionFlux2 = cI_hetero.kdimF*cI_wt*cI_DN-cI_hetero.kdimR*cI_mixed 
ReactionFlux3 = cI_DN_dimerize.kdimF*cI_DN*cI_DN-
cI_DN_dimerize.kdimR*cI_DN_dimer 
ReactionFlux4 = kdeg*cI_wt 
ReactionFlux5 = kdeg2*cI_DN 
ReactionFlux6 = kbind0F*cI_dimer*pRM_D0-kbind0R*pRM_D1 
ReactionFlux7 = kbind1F*cI_dimer*pRM_D1-kbind1R*pRM_D2 
ReactionFlux8 = kbind2F*cI_dimer*pRM_D2-kbind2R 
ReactionFlux9 = basal_txn_D0.ktxn*pRM_D0 
ReactionFlux10 = basal_txn_D1.ktxn*pRM_D1 
ReactionFlux11 = activated_txn.ktxn*pRM_D2 
ReactionFlux12 = ktln*lacZ_mRNA 
ReactionFlux13 = kdeg_pro*lacZ_pro 
ReactionFlux14 = kdeg_mRNA*lacZ_mRNA 
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Table C.3. Model Parameters 
 
cI_dimerize.kdimR = 1 
cI_dimerize.kdimF = 0.05 
cI_hetero.kdimF = 0.05 
cI_hetero.kdimR = 1 
cI_DN_dimerize.kdimF = 0.05 
cI_DN_dimerize.kdimR = 1 
kdeg = 0.01 
kdeg2 = 1 
kbind0F = 0.33 
kbind0R = 1 
kbind1F = 0.66 
kbind1R = 1 
kbind2F = 0.03 
kbind2R = 1 
basal_txn_D0.ktxn = 10 
basal_txn_D1.ktxn = 10 
activated_txn.ktxn = 110 
ktln = 1 
kdeg_pro = 0.01 
kdeg_mRNA = 10 
cell = 1 
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